Cell-specific	O
differences	O
in	O
activation	O
of	O
NF-kappa	B-DNA
B	I-DNA
regulatory	I-DNA
elements	I-DNA
of	O
human	B-DNA
immunodeficiency	I-DNA
virus	I-DNA
and	I-DNA
beta	I-DNA
interferon	I-DNA
promoters	I-DNA
by	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
.	O

Three	O
aspects	O
of	O
the	O
involvement	O
of	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
in	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
pathogenesis	O
were	O
examined	O
.	O

Tumor	B-RNA
necrosis	I-RNA
factor	I-RNA
alpha	I-RNA
(	I-RNA
TNF-alpha	I-RNA
)	I-RNA
mRNA	I-RNA
production	O
was	O
analyzed	O
by	O
polymerase	O
chain	O
reaction	O
amplification	O
in	O
monocytic	B-cell_line
U937	I-cell_line
cells	I-cell_line
and	O
in	O
a	O
chronically	B-cell_line
HIV	I-cell_line
infected	I-cell_line
U937	I-cell_line
cell	I-cell_line
line	I-cell_line
(	O
U9-IIIB	B-cell_line
)	O
.	O

TNF-alpha	B-RNA
RNA	I-RNA
was	O
undetectable	O
in	O
U937	B-cell_line
cells	I-cell_line
,	O
whereas	O
a	O
low	O
constitutive	O
level	O
was	O
detected	O
in	O
U9-IIIB	B-cell_line
cells	I-cell_line
.	O

Paramyxovirus	O
infection	O
induced	O
a	O
5-	O
to	O
10-fold	O
increase	O
in	O
the	O
steady-state	O
level	O
of	O
TNF-alpha	B-RNA
RNA	I-RNA
in	O
U9-IIIB	B-cell_line
cells	I-cell_line
compared	O
with	O
U937	B-cell_line
cells	I-cell_line
,	O
suggesting	O
that	O
HIV-infected	B-cell_line
monocytic	I-cell_line
cells	I-cell_line
produced	O
higher	O
levels	O
of	O
TNF-alpha	B-protein
than	O
did	O
normal	O
cells	O
after	O
a	O
secondary	O
virus	O
infection	O
.	O

The	O
effects	O
of	O
TNF-alpha	B-protein
on	O
gene	O
expression	O
were	O
examined	O
by	O
transient	O
expression	O
assays	O
using	O
reporter	B-DNA
chloramphenicol	I-DNA
acetyltransferase	I-DNA
plasmids	I-DNA
linked	O
to	O
regulatory	B-DNA
elements	I-DNA
from	O
the	O
HIV	B-DNA
long	I-DNA
terminal	I-DNA
repeat	I-DNA
(	O
LTR	B-DNA
)	O
and	O
the	O
beta	B-DNA
interferon	I-DNA
promoter	I-DNA
.	O

In	O
U937	B-cell_line
and	I-cell_line
Jurkat	I-cell_line
T	I-cell_line
lymphoid	I-cell_line
cells	I-cell_line
,	O
the	O
inducibility	O
of	O
the	O
different	O
hybrid	B-DNA
promoters	I-DNA
by	O
TNF-alpha	B-protein
or	O
phorbol	O
ester	O
varied	O
in	O
a	O
cell	O
type-	O
and	O
promoter	O
context-specific	O
manner	O
;	O
the	O
levels	O
of	O
gene	O
activity	O
of	O
NF-kappa	B-DNA
B-containing	I-DNA
plasmids	I-DNA
correlated	O
directly	O
with	O
induction	O
of	O
NF-kappa	B-protein
B	I-protein
DNA-binding	O
activity	O
.	O

Although	O
the	O
intact	O
beta	B-DNA
interferon	I-DNA
promoter	I-DNA
was	O
only	O
weakly	O
stimulated	O
by	O
phorbol	O
ester	O
or	O
TNF-alpha	B-protein
,	O
multimers	O
of	O
the	O
PRDII	B-DNA
NF-kappa	I-DNA
B-binding	I-DNA
domain	I-DNA
were	O
inducible	O
by	O
both	O
agents	O
.	O

TNF-alpha	B-protein
was	O
able	O
to	O
increase	O
expression	O
of	O
the	O
HIV	B-DNA
LTR	I-DNA
in	O
T	B-cell_type
cells	I-cell_type
,	O
but	O
in	O
monocytic	B-cell_type
cells	I-cell_type
,	O
TNF-alpha	B-protein
did	O
not	O
induce	O
the	O
HIV	B-DNA
LTR	I-DNA
above	O
a	O
constitutive	O
level	O
of	O
activity	O
.	O

This	O
level	O
of	O
NF-kappa	B-protein
B	I-protein
-independent	O
activity	O
appears	O
to	O
be	O
sufficient	O
for	O
virus	O
multiplication	O
,	O
since	O
TNF-alpha	B-protein
treatment	O
had	O
no	O
effect	O
on	O
the	O
kinetics	O
of	O
de	O
novo	O
HIV	O
type	O
1	O
(	O
HIV-1	O
)	O
infection	O
and	O
viral	B-RNA
RNA	I-RNA
production	O
in	O
U937	B-cell_line
cells	I-cell_line
.	O

However	O
,	O
in	O
Jurkat	B-cell_line
cells	I-cell_line
,	O
TNF-alpha	B-protein
dramatically	O
enhanced	O
the	O
spread	O
of	O
HIV-1	O
through	O
the	O
cell	O
population	O
and	O
increased	O
viral	B-RNA
RNA	I-RNA
synthesis	O
,	O
indicating	O
that	O
in	O
T	B-cell_type
cells	I-cell_type
HIV-1	O
multiplication	O
was	O
stimulated	O
by	O
TNF-alpha	B-protein
treatment	O
.	O

JournaAL	NULL
or	NULL
ViroLoGY	NULL
,	NULL
Oct.	NULL
1990	NULL
,	NULL
p.	NULL
4726-4734	NULL
0022-538	NULL
X/90/104726-09	NULL
$	NULL
02.00/0	NULL
Copyright	NULL
©	NULL
1990	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

64	NULL
,	NULL
No	NULL
.	NULL

10	NULL
Cell-Specific	NULL
Differences	NULL
in	NULL
Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
Regulatory	NULL
Elements	NULL
of	NULL
Human	NULL
Immunodeficiency	NULL
Virus	NULL
and	NULL
Beta	NULL
Interferon	NULL
Promoters	NULL
by	NULL
Tumor	NULL
Necrosis	NULL
Factor	NULL
J.	NULL
LACOSTE	NULL
,	NULL
M.	NULL
D'ADDARIO	NULL
,	NULL
A.	NULL
ROULSTON	NULL
,	NULL
M.	NULL
A.	NULL
WAINBERG	NULL
,	NULL
anp	NULL
J.	NULL
HISCOTT*	NULL
Lady	NULL
Davis	NULL
Institute	NULL
for	NULL
Medical	NULL
Research-Sir	NULL
Mortimer	NULL
B.	NULL
Davis	NULL
Jewish	NULL
General	NULL
Hospital	NULL
,	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
and	NULL
McGill	NULL
AIDS	NULL
Centre	NULL
,	NULL
McGill	NULL
University	NULL
,	NULL
Montreal	NULL
,	NULL
Quebec	NULL
,	NULL
Canada	NULL
H3T	NULL
1E2	NULL
Received	NULL
8	NULL
March	NULL
1990/Accepted	NULL
11	NULL
June	NULL
1990	NULL
Three	NULL
aspects	NULL
of	NULL
the	NULL
involvement	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
in	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
pathogenesis	NULL
were	NULL
examined	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
(	NULL
TNF-a	NULL
)	NULL
mRNA	NULL
production	NULL
was	NULL
analyzed	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
amplification	NULL
in	NULL
monocytic	NULL
U937	NULL
cells	NULL
and	NULL
in	NULL
a	NULL
chronically	NULL
HIV	NULL
infected	NULL
U937	NULL
cell	NULL
line	NULL
(	NULL
U9-IIIB	NULL
)	NULL
.	NULL

TNF-a	NULL
RNA	NULL
was	NULL
undetectable	NULL
in	NULL
U937	NULL
cells	NULL
,	NULL
whereas	NULL
a	NULL
low	NULL
constitutive	NULL
level	NULL
was	NULL
detected	NULL
in	NULL
U9-IIIB	NULL
cells	NULL
.	NULL

Paramyxovirus	NULL
infection	NULL
induced	NULL
a	NULL
5-	NULL
to	NULL
10-fold	NULL
increase	NULL
in	NULL
the	NULL
steady-state	NULL
level	NULL
of	NULL
TNF-a	NULL
RNA	NULL
in	NULL
U9-IIIB	NULL
cells	NULL
compared	NULL
with	NULL
U937	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
HIV-infected	NULL
monocytic	NULL
cells	NULL
produced	NULL
higher	NULL
levels	NULL
of	NULL
TNF-a	NULL
than	NULL
did	NULL
normal	NULL
cells	NULL
after	NULL
a	NULL
secondary	NULL
virus	NULL
infection	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
TNF-a	NULL
on	NULL
gene	NULL
expression	NULL
were	NULL
examined	NULL
by	NULL
transient	NULL
expression	NULL
assays	NULL
using	NULL
reporter	NULL
chloramphenicol	NULL
acetyltransferase	NULL
plasmids	NULL
linked	NULL
to	NULL
regulatory	NULL
elements	NULL
from	NULL
the	NULL
HIV	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
and	NULL
the	NULL
beta	NULL
interferon	NULL
promoter	NULL
.	NULL

In	NULL
U937	NULL
and	NULL
Jurkat	NULL
T	NULL
lymphoid	NULL
cells	NULL
,	NULL
the	NULL
inducibility	NULL
of	NULL
the	NULL
different	NULL
hybrid	NULL
promoters	NULL
by	NULL
TNF-a	NULL
or	NULL
phorbol	NULL
ester	NULL
varied	NULL
in	NULL
a	NULL
cell	NULL
type-	NULL
and	NULL
promoter	NULL
context-specific	NULL
manner	NULL
;	NULL
the	NULL
levels	NULL
of	NULL
gene	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B-containing	NULL
plasmids	NULL
correlated	NULL
directly	NULL
with	NULL
induction	NULL
of	NULL
NF-xB	NULL
DNA-binding	NULL
activity	NULL
.	NULL

Although	NULL
the	NULL
intact	NULL
beta	NULL
interferon	NULL
promoter	NULL
was	NULL
only	NULL
weakly	NULL
stimulated	NULL
by	NULL
phorbol	NULL
ester	NULL
or	NULL
TNF-	NULL
«	NULL
,	NULL
multimers	NULL
of	NULL
the	NULL
PRDII	NULL
NF-B-binding	NULL
domain	NULL
were	NULL
inducible	NULL
by	NULL
both	NULL
agents	NULL
.	NULL

TNF-	NULL
«	NULL
was	NULL
able	NULL
to	NULL
increase	NULL
expression	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
but	NULL
in	NULL
monocytic	NULL
cells	NULL
,	NULL
TNF-a	NULL
«	NULL
did	NULL
not	NULL
induce	NULL
the	NULL
HIV	NULL
LTR	NULL
above	NULL
a	NULL
constitutive	NULL
level	NULL
of	NULL
activity	NULL
.	NULL

This	NULL
level	NULL
of	NULL
NF-	NULL
«	NULL
B-independent	NULL
activity	NULL
appears	NULL
to	NULL
be	NULL
sufficient	NULL
for	NULL
virus	NULL
multiplication	NULL
,	NULL
since	NULL
TNF-a	NULL
treatment	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
kinetics	NULL
of	NULL
de	NULL
novo	NULL
HIV	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
infection	NULL
and	NULL
viral	NULL
RNA	NULL
production	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
TNF-a	NULL
dramatically	NULL
enhanced	NULL
the	NULL
spread	NULL
of	NULL
HIV-1	NULL
through	NULL
the	NULL
cell	NULL
population	NULL
and	NULL
increased	NULL
viral	NULL
RNA	NULL
synthesis	NULL
,	NULL
indicating	NULL
that	NULL
in	NULL
T	NULL
cells	NULL
HIV-1	NULL
multiplication	NULL
was	NULL
stimulated	NULL
by	NULL
TNF-a	NULL
treatment	NULL
.	NULL

A	NULL
critical	NULL
component	NULL
of	NULL
nonadaptive	NULL
immunity	NULL
is	NULL
the	NULL
release	NULL
of	NULL
soluble	NULL
mediators	NULL
that	NULL
affect	NULL
diverse	NULL
biological	NULL
processes	NULL
such	NULL
as	NULL
immune	NULL
responsiveness	NULL
,	NULL
differentiation	NULL
,	NULL
and	NULL
cell	NULL
proliferation	NULL
.	NULL

In	NULL
response	NULL
to	NULL
foreign	NULL
antigens	NULL
,	NULL
cells	NULL
of	NULL
the	NULL
monocyte/macrophage	NULL
lineage	NULL
produce	NULL
a	NULL
variety	NULL
of	NULL
peptide	NULL
hormones	NULL
or	NULL
cytokines	NULL
that	NULL
bind	NULL
to	NULL
their	NULL
cognate	NULL
receptors	NULL
on	NULL
target	NULL
cells	NULL
and	NULL
transduce	NULL
signals	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Often	NULL
the	NULL
consequence	NULL
of	NULL
signal	NULL
transduction	NULL
is	NULL
the	NULL
modulation	NULL
of	NULL
gene	NULL
expression	NULL
,	NULL
mediated	NULL
by	NULL
changes	NULL
in	NULL
the	NULL
activity	NULL
or	NULL
amount	NULL
of	NULL
specific	NULL
transcription	NULL
factors	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Many	NULL
viruses	NULL
target	NULL
infection	NULL
to	NULL
myeloid	NULL
cells	NULL
,	NULL
resulting	NULL
in	NULL
compromise	NULL
of	NULL
monocyte/macrophage	NULL
function	NULL
.	NULL

Dysregulation	NULL
of	NULL
the	NULL
mechanisms	NULL
that	NULL
control	NULL
cytokine	NULL
production	NULL
in	NULL
myeloid	NULL
cells	NULL
may	NULL
have	NULL
deleterious	NULL
consequences	NULL
on	NULL
immune	NULL
responsiveness	NULL
,	NULL
inflammation	NULL
,	NULL
and	NULL
viral	NULL
pathogenesis	NULL
.	NULL

Peripheral	NULL
blood	NULL
monocytes	NULL
,	NULL
tissue	NULL
macrophages	NULL
,	NULL
and	NULL
bone	NULL
marrow-derived	NULL
immature	NULL
myeloblasts	NULL
express	NULL
the	NULL
CD4	NULL
cell	NULL
surface	NULL
antigen	NULL
,	NULL
the	NULL
cellular	NULL
receptor	NULL
for	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
(	NULL
8	NULL
,	NULL
30	NULL
)	NULL
,	NULL
and	NULL
,	NULL
like	NULL
T	NULL
helper	NULL
lymphocytes	NULL
,	NULL
are	NULL
subject	NULL
to	NULL
HIV-1	NULL
infection	NULL
at	NULL
high	NULL
frequency	NULL
(	NULL
1	NULL
,	NULL
3	NULL
,	NULL
13	NULL
,	NULL
17-19	NULL
,	NULL
26	NULL
,	NULL
35	NULL
,	NULL
45	NULL
)	NULL
.	NULL

These	NULL
cells	NULL
generally	NULL
do	NULL
not	NULL
show	NULL
extensive	NULL
cytopathology	NULL
and	NULL
thus	NULL
may	NULL
serve	NULL
as	NULL
reservoirs	NULL
for	NULL
viral	NULL
persistence	NULL
and	NULL
spread	NULL
to	NULL
peripheral	NULL
tissues	NULL
(	NULL
11	NULL
,	NULL
46	NULL
)	NULL
.	NULL

The	NULL
distinction	NULL
between	NULL
a	NULL
lytic	NULL
versus	NULL
more	NULL
latent	NULL
state	NULL
of	NULL
HIV	NULL
infection	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
complex	NULL
interplay	NULL
between	NULL
HIV	NULL
regulatory	NULL
proteins	NULL
,	NULL
host	NULL
cellular	NULL
proteins	NULL
,	NULL
cis-acting	NULL
DNA	NULL
sequences	NULL
within	NULL
the	NULL
HIV	NULL
long	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

4726	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
,	NULL
and	NULL
antigenic	NULL
stimulation	NULL
of	NULL
HIV-infected	NULL
cells	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
7	NULL
)	NULL
.	NULL

HIV	NULL
pathogenesis	NULL
may	NULL
also	NULL
be	NULL
influenced	NULL
by	NULL
the	NULL
secretion	NULL
of	NULL
cytokines	NULL
that	NULL
influence	NULL
HIV	NULL
multiplication	NULL
(	NULL
6	NULL
,	NULL
11	NULL
,	NULL
12	NULL
,	NULL
38	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
monocyte-derived	NULL
cytokines	NULL
such	NULL
as	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
(	NULL
TNF-	NULL
«	NULL
)	NULL
and	NULL
interleukin-1	NULL
(	NULL
IL-1	NULL
)	NULL
have	NULL
been	NULL
shown	NULL
recently	NULL
to	NULL
stimulate	NULL
HIV-1	NULL
transcription	NULL
via	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
two	NULL
recognition	NULL
sequences	NULL
within	NULL
the	NULL
HIV-1	NULL
transcriptional	NULL
enhancer	NULL
(	NULL
9	NULL
,	NULL
28	NULL
,	NULL
41	NULL
,	NULL
43	NULL
,	NULL
44	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
may	NULL
be	NULL
stimulated	NULL
by	NULL
multiple	NULL
activation	NULL
mechanisms	NULL
,	NULL
including	NULL
coinfection	NULL
with	NULL
other	NULL
viruses	NULL
,	NULL
differentiation-inducing	NULL
agents	NULL
,	NULL
and	NULL
antigenic	NULL
stimulation	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
33	NULL
)	NULL
.	NULL

It	NULL
is	NULL
now	NULL
recognized	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
a	NULL
pleiotropic	NULL
mediator	NULL
of	NULL
gene	NULL
regulation	NULL
involved	NULL
in	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
several	NULL
immunoregulatory	NULL
genes	NULL
,	NULL
cytokines	NULL
,	NULL
and	NULL
viral	NULL
promoters	NULL
(	NULL
33	NULL
)	NULL
.	NULL

NF-kB	NULL
exists	NULL
in	NULL
the	NULL
cytoplasm	NULL
in	NULL
a	NULL
latent	NULL
form	NULL
as	NULL
a	NULL
p6S-p50	NULL
heterodimer	NULL
coupled	NULL
to	NULL
an	NULL
inhibitor	NULL
molecule	NULL
termed	NULL
IxB	NULL
;	NULL
activation	NULL
is	NULL
a	NULL
posttranslational	NULL
event	NULL
that	NULL
involves	NULL
dissociation	NULL
from	NULL
IxB	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
DNA-binding	NULL
activity	NULL
(	NULL
2	NULL
,	NULL
53	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
the	NULL
involvement	NULL
of	NULL
TNF-a	NULL
in	NULL
HIV	NULL
pathogenesis	NULL
was	NULL
examined	NULL
in	NULL
monocytic	NULL
and	NULL
T	NULL
lymphoid	NULL
cells	NULL
.	NULL

TNF-	NULL
«	NULL
mRNA	NULL
production	NULL
was	NULL
analyzed	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
amplification	NULL
in	NULL
monocytic	NULL
U937	NULL
cells	NULL
and	NULL
in	NULL
a	NULL
chronically	NULL
HIV	NULL
infected	NULL
U937-derived	NULL
cell	NULL
line	NULL
after	NULL
coinfection	NULL
with	NULL
Sendai	NULL
virus	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
TNF-a	NULL
or	NULL
phorbol	NULL
ester	NULL
treatment	NULL
on	NULL
protein-DNA	NULL
interactions	NULL
and	NULL
expression	NULL
of	NULL
plasmids	NULL
containing	NULL
HIV	NULL
LTR	NULL
and	NULL
beta	NULL
interferon	NULL
(	NULL
IFN-B	NULL
)	NULL
regulatory	NULL
elements	NULL
were	NULL
measured	NULL
Vor	NULL
.	NULL

64	NULL
,	NULL
1990	NULL
B	NULL
|	NULL
|	NULL
aq	NULL
DN	NULL
ol	NULL
ra	NULL
iv	NULL
)	NULL
l	NULL
PCR	NULL
reaction	NULL
:	NULL
.	NULL

J	NULL
4	NULL
denaturation	NULL
95°C	NULL
————l	NULL
:	NULL
annealing	NULL
50°C	NULL
*-	NULL
*	NULL
extension	NULL
72°C	NULL
30	NULL
cycles	NULL
Relative	NULL
RNA	NULL
Levels	NULL
Cells	NULL
by	NULL
transient	NULL
expression	NULL
assays	NULL
and	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

Also	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
TNF-a	NULL
on	NULL
the	NULL
kinetics	NULL
of	NULL
HIV-1	NULL
multiplication	NULL
and	NULL
viral	NULL
RNA	NULL
accumulation	NULL
were	NULL
monitored	NULL
during	NULL
de	NULL
novo	NULL
infection	NULL
of	NULL
U937	NULL
and	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
experimental	NULL
results	NULL
suggest	NULL
that	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
HIV-1	NULL
gene	NULL
activity	NULL
and	NULL
multiplication	NULL
were	NULL
dependent	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
;	NULL
in	NULL
monocytic	NULL
cells	NULL
,	NULL
although	NULL
NF-kB	NULL
activity	NULL
was	NULL
inducible	NULL
by	NULL
TNF-a	NULL
and	NULL
phorbol-12-myristate-13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
,	NULL
it	NULL
was	NULL
not	NULL
required	NULL
for	NULL
HIV	NULL
LTR	NULL
activity	NULL
or	NULL
HIV-1	NULL
replication	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
culture	NULL
and	NULL
virus	NULL
infection	NULL
.	NULL

U937	NULL
,	NULL
a	NULL
human	NULL
monocytic	NULL
line	NULL
,	NULL
and	NULL
Jurkat	NULL
,	NULL
a	NULL
human	NULL
T	NULL
lymphoid	NULL
cell	NULL
line	NULL
,	NULL
were	NULL
grown	NULL
EFFECT	NULL
OF	NULL
TNF-	NULL
«	NULL
ON	NULL
HIV	NULL
AND	NULL
IFN-B	NULL
GENE	NULL
EXPRESSION	NULL
4727	NULL
B	NULL
oan	NULL
tt	NULL
-	NULL
192	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
the	NULL
TNF-	NULL
«	NULL
gene	NULL
and	NULL
PCR	NULL
amplification	NULL
of	NULL
TNF-a	NULL
mRNA	NULL
.	NULL

i	NULL
,	NULL
The	NULL
four	NULL
exons	NULL
(	NULL
labeled	NULL
I	NULL
,	NULL
II	NULL
,	NULL
III	NULL
,	NULL
and	NULL
IV	NULL
)	NULL
,	NULL
the	NULL
5¢	NULL
and	NULL
3	NULL
'	NULL
untranslated	NULL
regions	NULL
(	NULL
)	NULL
,	NULL
and	NULL
the	NULL
coding	NULL
regions	NULL
(	NULL
RWW	NULL
)	NULL
of	NULL
TNF-a	NULL
(	NULL
42	NULL
)	NULL
;	NULL
ii	NULL
,	NULL
the	NULL
mature	NULL
TNF-a	NULL
mRNA	NULL
and	NULL
the	NULL
site	NULL
of	NULL
primer	NULL
B	NULL
used	NULL
in	NULL
reverse	NULL
transcription	NULL
;	NULL
iii	NULL
,	NULL
TNF-a	NULL
cDNA	NULL
and	NULL
the	NULL
location	NULL
of	NULL
primers	NULL
A	NULL
and	NULL
B	NULL
;	NULL
iv	NULL
,	NULL
the	NULL
412-base-pair	NULL
amplified	NULL
product	NULL
and	NULL
the	NULL
amplification	NULL
conditions	NULL
;	NULL
the	NULL
94-	NULL
and	NULL
85-base-pair	NULL
fragments	NULL
derived	NULL
by	NULL
Pvull	NULL
cleavage	NULL
can	NULL
be	NULL
detected	NULL
on	NULL
the	NULL
gel	NULL
as	NULL
fragments	NULL
(	NULL
*	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
RNA	NULL
analysis	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
2	NULL
g	NULL
)	NULL
isolated	NULL
from	NULL
uninduced	NULL
and	NULL
Sendai	NULL
virus-induced	NULL
U937	NULL
and	NULL
U9-IIIB	NULL
cells	NULL
was	NULL
amplified	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
and	NULL
analyzed	NULL
on	NULL
a	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
5	NULL
,	NULL
and	NULL
9	NULL
,	NULL
RNA	NULL
from	NULL
untreated	NULL
U937	NULL
cells	NULL
;	NULL
2	NULL
,	NULL
6	NULL
,	NULL
and	NULL
10	NULL
,	NULL
RNA	NULL
from	NULL
Sendai	NULL
virus-induced	NULL
U937	NULL
cells	NULL
at	NULL
8	NULL
h	NULL
p.i	NULL
.	NULL

;	NULL
3	NULL
,	NULL
7	NULL
,	NULL
and	NULL
11	NULL
,	NULL
RNA	NULL
from	NULL
untreated	NULL
U9-IIIB	NULL
cells	NULL
;	NULL
4	NULL
,	NULL
8	NULL
,	NULL
and	NULL
12	NULL
,	NULL
RNA	NULL
from	NULL
Sendai	NULL
virus-induced	NULL
UY-IIIB	NULL
cells	NULL
at	NULL
8	NULL
h	NULL
p.i	NULL
.	NULL

In	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
,	NULL
TNF-a	NULL
primers	NULL
were	NULL
used	NULL
to	NULL
generate	NULL
a	NULL
TNF-	NULL
«	NULL
-specific	NULL
signal	NULL
(	NULL
412	NULL
bases	NULL
)	NULL
;	NULL
in	NULL
each	NULL
of	NULL
these	NULL
samples	NULL
,	NULL
10~®	NULL
pug	NULL
of	NULL
SV2CAT	NULL
DNA	NULL
was	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
after	NULL
the	NULL
reverse	NULL
transcriptase	NULL
step	NULL
and	NULL
coamplified	NULL
with	NULL
SV2CAT-specific	NULL
primers	NULL
to	NULL
generate	NULL
a	NULL
signal	NULL
of	NULL
303	NULL
bases	NULL
.	NULL

In	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
,	NULL
GAPDH	NULL
primers	NULL
generated	NULL
a	NULL
GAPDH	NULL
signal	NULL
of	NULL
196	NULL
bases	NULL
.	NULL

Lanes	NULL
9	NULL
to	NULL
12	NULL
contain	NULL
TNF-a	NULL
primers	NULL
without	NULL
the	NULL
reverse	NULL
transcriptase	NULL
step	NULL
.	NULL

Lane	NULL
M	NULL
,	NULL
Marker	NULL
plasmid	NULL
pAT153	NULL
cleaved	NULL
with	NULL
Haelll	NULL
and	NULL
end	NULL
labeled	NULL
with	NULL
polynucleotide	NULL
kinase	NULL
and	NULL
[	NULL
y-P	NULL
]	NULL
ATP	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Determination	NULL
of	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
PCR	NULL
products	NULL
by	NULL
laser	NULL
densitometry	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
TNF-	NULL
«	NULL
RNA	NULL
(	NULL
@	NULL
)	NULL
was	NULL
quantified	NULL
relative	NULL
to	NULL
10~®	NULL
pg	NULL
of	NULL
SV2CAT	NULL
DNA	NULL
(	NULL
©	NULL
)	NULL
and	NULL
GAPDH	NULL
RNA	NULL
(	NULL
M	NULL
)	NULL
.	NULL

in	NULL
RPMI	NULL
medium	NULL
(	NULL
GIBCO	NULL
Laboratories	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
calf	NULL
serum	NULL
(	NULL
Hyclone	NULL
)	NULL
,	NULL
glutamine	NULL
,	NULL
and	NULL
antibiotics	NULL
.	NULL

U9-IIIB	NULL
,	NULL
a	NULL
derivative	NULL
of	NULL
U937	NULL
cells	NULL
chronically	NULL
infected	NULL
with	NULL
HIV-1	NULL
strain	NULL
IHB	NULL
,	NULL
were	NULL
grown	NULL
in	NULL
the	NULL
same	NULL
medium	NULL
except	NULL
that	NULL
5	NULL
%	NULL
fetal	NULL
calf-5	NULL
%	NULL
calf	NULL
serum	NULL
was	NULL
used	NULL
.	NULL

HIV-1	NULL
infection	NULL
of	NULL
U937	NULL
cells	NULL
was	NULL
initiated	NULL
by	NULL
mixing	NULL
U937	NULL
cells	NULL
and	NULL
virus-shedding	NULL
UQ-IIIB	NULL
cells	NULL
at	NULL
a	NULL
ratio	NULL
of	NULL
100:1	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
infected	NULL
with	NULL
HIV-1	NULL
(	NULL
strain	NULL
IIIB	NULL
)	NULL
derived	NULL
from	NULL
H9	NULL
cell	NULL
supernatants	NULL
at	NULL
a	NULL
multiplicity	NULL
of	NULL
infection	NULL
of	NULL
approximately	NULL
0.1	NULL
PFU	NULL
per	NULL
cell	NULL
.	NULL

TNF-a	NULL
(	NULL
100	NULL
U/ml	NULL
;	NULL
Genzyme	NULL
)	NULL
was	NULL
added	NULL
to	NULL
cells	NULL
at	NULL
24	NULL
h	NULL
postinfection	NULL
(	NULL
p.i	NULL
.	NULL
)	NULL

.	NULL

Indirect	NULL
immunofluorescence	NULL
on	NULL
acetone-methanol	NULL
(	NULL
1:1	NULL
)	NULL
-fixed	NULL
HIV-infected	NULL
cells	NULL
was	NULL
performed	NULL
essentially	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
12	NULL
)	NULL
.	NULL

For	NULL
4728	NULL
LACOSTE	NULL
ET	NULL
AL	NULL
.	NULL

Sendai	NULL
virus	NULL
infection	NULL
,	NULL
cells	NULL
were	NULL
infected	NULL
with	NULL
500	NULL
hemag-glutinating	NULL
units	NULL
of	NULL
virus	NULL
for	NULL
2	NULL
h	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

Plasmid	NULL
constructions	NULL
and	NULL
oligonucleotide	NULL
synthesis	NULL
.	NULL

Plasmids	NULL
SV2CAT	NULL
,	NULL
SV1CAT	NULL
,	NULL
HIV/CAT	NULL
,	NULL
and	NULL
SVS5B	NULL
have	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
22	NULL
,	NULL
41	NULL
,	NULL
51	NULL
)	NULL
.	NULL

Other	NULL
plasmids	NULL
were	NULL
obtained	NULL
by	NULL
inserting	NULL
synthetic	NULL
oligonucleotides	NULL
into	NULL
the	NULL
enhancerless	NULL
Accl-Sphl-cleaved	NULL
SV1CAT	NULL
vector	NULL
.	NULL

Oligonucleotides	NULL
were	NULL
synthesized	NULL
on	NULL
a	NULL
Pharmacia	NULL
Gene	NULL
Assembler	NULL
,	NULL
purified	NULL
on	NULL
denaturing	NULL
polyacrylamide	NULL
gels	NULL
,	NULL
and	NULL
reannealed	NULL
to	NULL
generate	NULL
double-stranded	NULL
synthetic	NULL
oligonucleotides	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
plus	NULL
strands	NULL
of	NULL
the	NULL
oligonucleotides	NULL
are	NULL
as	NULL
follows	NULL
:	NULL
P1	NULL
,	NULL
5-GGGAGAAGTGAAAGTG-3	NULL
'	NULL
;	NULL
P2	NULL
,	NULL
5-GG	NULL
GAAATTCCGGGAAATTCC-3	NULL
'	NULL
;	NULL
P5	NULL
,	NULL
5S-ATAGGAAAACT	NULL
GAAAGG-3	NULL
'	NULL
;	NULL
HIV	NULL
kB	NULL
,	NULL
5-AGGGACTTTCCGCTGGGGAC	NULL
TTTCC-3	NULL
'	NULL
;	NULL
and	NULL
HIV	NULL
«	NULL
kB	NULL
(	NULL
m	NULL
)	NULL
,	NULL
S-ACATGGTTTCCGCTGCA	NULL
TGGTTTCC-3	NULL
'	NULL
.	NULL

Transient	NULL
expression	NULL
assays	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
(	NULL
23	NULL
)	NULL
,	NULL
and	NULL
U937	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
,	NULL
using	NULL
the	NULL
Bio-Rad	NULL
Gene	NULL
Pulser	NULL
(	NULL
0.25	NULL
kV	NULL
,	NULL
960	NULL
wF	NULL
)	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
3	NULL
x	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
15	NULL
ug	NULL
of	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
reporter	NULL
plasmids	NULL
,	NULL
and	NULL
at	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
they	NULL
were	NULL
treated	NULL
with	NULL
PMA	NULL
(	NULL
25	NULL
ng/m	NULL
!	NULL
)	NULL

or	NULL
with	NULL
TNF-a	NULL
(	NULL
100	NULL
U/ml	NULL
;	NULL
Genzyme	NULL
)	NULL
.	NULL

At	NULL
20	NULL
h	NULL
after	NULL
induction	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
assayed	NULL
for	NULL
accumulated	NULL
CAT	NULL
activity	NULL
.	NULL

Protein	NULL
concentrations	NULL
were	NULL
determined	NULL
by	NULL
the	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
.	NULL

Protein	NULL
(	NULL
10	NULL
to	NULL
30	NULL
pg	NULL
)	NULL
was	NULL
assayed	NULL
for	NULL
15	NULL
min	NULL
to	NULL
3	NULL
h.	NULL
Percent	NULL
acetylation	NULL
was	NULL
determined	NULL
,	NULL
and	NULL
the	NULL
relative	NULL
inducibility	NULL
was	NULL
obtained	NULL
by	NULL
dividing	NULL
percent	NULL
conversion	NULL
of	NULL
treated	NULL
versus	NULL
untreated	NULL
samples	NULL
.	NULL

WCE	NULL
preparations	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
(	NULL
WCE	NULL
)	NULL
were	NULL
prepared	NULL
from	NULL
U937	NULL
and	NULL
Jurkat	NULL
cells	NULL
(	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
)	NULL
after	NULL
induction	NULL
for	NULL
8	NULL
h	NULL
with	NULL
PMA	NULL
(	NULL
25	NULL
ng/ml	NULL
)	NULL
or	NULL
TNF-	NULL
«	NULL
(	NULL
100	NULL
U/ml	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
,	NULL
washed	NULL
once	NULL
with	NULL
1	NULL
volume	NULL
of	NULL
cold	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
and	NULL
suspended	NULL
in	NULL
WCE	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic	NULL
acid	NULL
[	NULL
HEPES	NULL
]	NULL
,	NULL
0.5	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
EGTA	NULL
,	NULL
0.5	NULL
mM	NULL
spermidine	NULL
,	NULL
0.15	NULL
mM	NULL
spermine	NULL
,	NULL
10	NULL
%	NULL
glyc-erol	NULL
,	NULL
10	NULL
mM	NULL
sodium	NULL
molybdate	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
)	NULL
containing	NULL
0.5	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
and	NULL
1	NULL
pug	NULL
each	NULL
of	NULL
pepstatin	NULL
,	NULL
aprotonin	NULL
,	NULL
and	NULL
leupeptin	NULL
per	NULL
ml	NULL
as	NULL
prote-ase	NULL
inhibitors	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
by	NULL
slowly	NULL
adding	NULL
2	NULL
M	NULL
KCl	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
0.5	NULL
M.	NULL
Lysates	NULL
were	NULL
gently	NULL
mixed	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
and	NULL
cellular	NULL
debris	NULL
was	NULL
removed	NULL
by	NULL
centrifu-gation	NULL
(	NULL
30,000	NULL
rpm	NULL
,	NULL
90	NULL
min	NULL
,	NULL
2°C	NULL
)	NULL
.	NULL

Supernatants	NULL
were	NULL
then	NULL
diluted	NULL
to	NULL
0.1	NULL
M	NULL
KCl	NULL
by	NULL
adding	NULL
WCE	NULL
buffer	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Final	NULL
protein	NULL
concentrations	NULL
were	NULL
determined	NULL
by	NULL
the	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
.	NULL

Gel	NULL
retardation	NULL
assays	NULL
.	NULL

A	NULL
10-	NULL
to	NULL
15-ug	NULL
sample	NULL
of	NULL
crude	NULL
WCE	NULL
protein	NULL
,	NULL
in	NULL
WCE	NULL
buffer	NULL
(	NULL
0.1	NULL
M	NULL
KCI	NULL
)	NULL
,	NULL
was	NULL
preincubated	NULL
with	NULL
5	NULL
pg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
as	NULL
nonspecific	NULL
competitor	NULL
DNA	NULL
for	NULL
10	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

y-*P-labeled	NULL
HIV	NULL
enhancer	NULL
probe	NULL
(	NULL
0.2	NULL
ng	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
WCE	NULL
for	NULL
20	NULL
to	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temper-ature	NULL
.	NULL

Competition	NULL
assays	NULL
were	NULL
performed	NULL
by	NULL
incubating	NULL
a	NULL
125-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
competitor	NULL
(	NULL
25	NULL
ng	NULL
)	NULL
with	NULL
the	NULL
WCE	NULL
for	NULL
10	NULL
min	NULL
on	NULL
ice	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
radiolabeled	NULL
probe	NULL
.	NULL

Samples	NULL
were	NULL
analyzed	NULL
on	NULL
native	NULL
5	NULL
%	NULL
acrylamide	NULL
gels	NULL
and	NULL
run	NULL
at	NULL
80	NULL
V	NULL
for	NULL
1.5	NULL
to	NULL
2.5	NULL
h.	NULL
Gels	NULL
were	NULL
dried	NULL
and	NULL
autoradiographed	NULL
for	NULL
about	NULL
15	NULL
h.	NULL
Oligonucleotides	NULL
were	NULL
5	NULL
'	NULL
end	NULL
labeled	NULL
with	NULL
[	NULL
y-	NULL
>	NULL
P	NULL
]	NULL
ATP	NULL
(	NULL
3,888	NULL
Ci/mmol	NULL
;	NULL
ICN	NULL
Radio-chemicals	NULL
)	NULL
and	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
Pharmacia	NULL
)	NULL
and	NULL
subsequently	NULL
applied	NULL
to	NULL
Sephadex	NULL
G-50	NULL
column	NULL
to	NULL
remove	NULL
unincorporated	NULL
nucleotides	NULL
.	NULL

PCR	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
uninduced	NULL
and	NULL
induced	NULL
U937	NULL
and	NULL
UO-IIIB	NULL
cells	NULL
by	NULL
a	NULL
modified	NULL
guanidium	NULL
isothiocyanate	NULL
procedure	NULL
(	NULL
5	NULL
)	NULL
and	NULL
treated	NULL
with	NULL
1	NULL
U	NULL
of	NULL
RNase-	NULL
J.	NULL
Viror	NULL
.	NULL

U3	NULL
R	NULL
o	NULL
--	NULL
HIV/CAT	NULL
-	NULL
-	NULL
{	NULL
777	NULL
THP	NULL
-	NULL
77	NULL
CAT	NULL
NF-xB	NULL
TAR	NULL
SV2CAT	NULL
|	NULL
=	NULL
~~	NULL
~	NULL
>	NULL
~-	NULL
}	NULL
~	NULL
}	NULL
CAT	NULL
Col	NULL
ee	NULL
cat	NULL
SV5B	NULL
-	NULL
CAT	NULL
IFN-B	NULL
P2	NULL
(	NULL
2YCAT	NULL
|	NULL
0	NULL
-	NULL
~~	NULL
~	NULL
~	NULL
c	NULL
~	NULL
e	NULL
-	NULL
}	NULL
}	NULL
>	NULL
cat	NULL
xB	NULL
(	NULL
3	NULL
}	NULL
/CAT	NULL
|	NULL
=	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
~	NULL
--	NULL
-	NULL
>	NULL
cat	NULL
|_	NULL
--	NULL
-	NULL
-	NULL
>	NULL
~	NULL
>	NULL
~~	NULL
~	NULL
>	NULL
cat	NULL
P5	NULL
(	NULL
4	NULL
)	NULL
/CAT	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Structure	NULL
of	NULL
hybrid	NULL
promoter-CAT	NULL
constructs	NULL
.	NULL

The	NULL
HIV	NULL
LTR	NULL
,	NULL
SV2CAT	NULL
,	NULL
and	NULL
SV5B	NULL
constructs	NULL
were	NULL
described	NULL
previously	NULL
(	NULL
13	NULL
,	NULL
27	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Synthetic	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
the	NULL
P1	NULL
,	NULL
P2	NULL
,	NULL
P5	NULL
,	NULL
and	NULL
HIV	NULL
enhancer	NULL
regions	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
were	NULL
subcloned	NULL
into	NULL
Accl-Sphl-cleaved	NULL
SVICAT	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Symbols	NULL
:	NULL
--	NULL
>	NULL
»	NULL
,	NULL
mRNA	NULL
start	NULL
site	NULL
;	NULL
CJ	NULL
,	NULL
the	NULL
SV40	NULL
G+C-rich	NULL
region	NULL
;	NULL
MMM	NULL
,	NULL
the	NULL
SV40	NULL
72-base-pair	NULL
repeats	NULL
;	NULL
,	NULL
the	NULL
HIV	NULL
LTR	NULL
region	NULL
(	NULL
-350	NULL
to	NULL
+80	NULL
)	NULL
,	NULL
with	NULL
the	NULL
enhancer	NULL
at	NULL
-105	NULL
to	NULL
-80	NULL
shown	NULL
;	NULL
E	NULL
,	NULL
the	NULL
IFN-	NULL
promoter	NULL
(	NULL
-287	NULL
to	NULL
+19	NULL
)	NULL
.	NULL

The	NULL
boxes	NULL
in	NULL
the	NULL
P2	NULL
(	NULL
2	NULL
)	NULL
,	NULL
P1	NULL
(	NULL
3	NULL
)	NULL
,	NULL
«	NULL
B	NULL
(	NULL
3	NULL
)	NULL
,	NULL
and	NULL
P5	NULL
(	NULL
4	NULL
)	NULL
plasmids	NULL
indicate	NULL
the	NULL
number	NULL
and	NULL
location	NULL
of	NULL
the	NULL
oligonucleotides	NULL
.	NULL

TAR	NULL
,	NULL
trans-activation-responsive	NULL
region	NULL
.	NULL

free	NULL
DNase	NULL
(	NULL
RQ1	NULL
DNase	NULL
;	NULL
Promega	NULL
Biotec	NULL
)	NULL
for	NULL
15	NULL
min	NULL
at	NULL
37°C	NULL
in	NULL
40	NULL
mM	NULL
Tris	NULL
hydrochloride	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
-10	NULL
mM	NULL
NaCl-6	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
.	NULL

RNA	NULL
was	NULL
phenol	NULL
extracted	NULL
,	NULL
ethanol	NULL
precipitated	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-70°C	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
2	NULL
pg	NULL
)	NULL
was	NULL
reverse	NULL
transcribed	NULL
with	NULL
200	NULL
U	NULL
of	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
reverse	NULL
transcriptase	NULL
(	NULL
Bethesda	NULL
Research	NULL
Laboratories	NULL
,	NULL
Inc.	NULL
)	NULL
and	NULL
10	NULL
pmol	NULL
of	NULL
primer	NULL
B	NULL
(	NULL
3	NULL
'	NULL
end	NULL
)	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
50	NULL
pl	NULL
.	NULL

PCR	NULL
amplication	NULL
(	NULL
40	NULL
)	NULL
was	NULL
performed	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
100	NULL
pl	NULL
,	NULL
using	NULL
25	NULL
pl	NULL
of	NULL
reverse	NULL
transcriptase	NULL
product	NULL
,	NULL
in	NULL
PCR	NULL
buffer	NULL
containing	NULL
100	NULL
mM	NULL
Tris	NULL
hydrochloride	NULL
(	NULL
pH	NULL
8.4	NULL
)	NULL
,	NULL
500	NULL
mM	NULL
KCI	NULL
,	NULL
15	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
100	NULL
pg	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
per	NULL
ml	NULL
,	NULL
the	NULL
four	NULL
deoxynucleoside	NULL
triphosphates	NULL
(	NULL
Pharmacia	NULL
)	NULL
at	NULL
2	NULL
mM	NULL
each	NULL
,	NULL
10	NULL
pmo	NULL
!	NULL

of	NULL
primer	NULL
A	NULL
(	NULL
5	NULL
'	NULL
end	NULL
)	NULL
,	NULL
10	NULL
pmol	NULL
of	NULL
primer	NULL
B	NULL
(	NULL
3	NULL
'	NULL
end	NULL
)	NULL
,	NULL
and	NULL
1.0	NULL
U	NULL
of	NULL
Taq	NULL
DNA	NULL
polymerase	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Amplification	NULL
(	NULL
30	NULL
cycles	NULL
)	NULL
was	NULL
carried	NULL
out	NULL
by	NULL
denaturing	NULL
at	NULL
95°C	NULL
for	NULL
5	NULL
min	NULL
,	NULL
annealing	NULL
at	NULL
50°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
and	NULL
extending	NULL
at	NULL
72°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
followed	NULL
by	NULL
denaturation	NULL
at	NULL
95°C	NULL
for	NULL
1.5	NULL
min	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
analyzed	NULL
on	NULL
a	NULL
4.5	NULL
%	NULL
denaturing	NULL
polyacrylamide	NULL
gel	NULL
(	NULL
19:1	NULL
cross-link-7	NULL
M	NULL
urea	NULL
)	NULL
and	NULL
autoradiographed	NULL
overnight	NULL
at	NULL
-70°C	NULL
.	NULL

Autoradiographs	NULL
were	NULL
obtained	NULL
Vor	NULL
.	NULL

64	NULL
,	NULL
1990	NULL
A	NULL
plasmids	NULL
s.	NULL
_	NULL
HIV/CAT	NULL
HIV/CAT	NULL
SV2CAT	NULL
SV1CAT	NULL
used	NULL
(	NULL
+TAT	NULL
)	NULL
EFFECT	NULL
OF	NULL
TNF-	NULL
«	NULL
ON	NULL
HIV	NULL
AND	NULL
GENE	NULL
EXPRESSION	NULL
4729	NULL
SV5p	NULL
P2	NULL
(	NULL
2	NULL
)	NULL
/CAT	NULL
xB	NULL
(	NULL
3	NULL
)	NULL
/CAT	NULL
P1	NULL
(	NULL
3	NULL
)	NULL
CAT	NULL
P5	NULL
(	NULL
4	NULL
)	NULL
CAT	NULL
treatment	NULL
»	NULL
u_	NULL
P	NULL
_	NULL
T	NULL
ou	NULL
P	NULL
IT	NULL
v	NULL
P	NULL
T	NULL
u	NULL
P	NULL
A	NULL
``	NULL
Ce	NULL
uns	NULL
,	NULL
?	NULL

“	NULL
~-	NULL
‘	NULL
Can	NULL
Rome	NULL
Se	NULL
CHD	NULL
|	NULL
cae	NULL
C	NULL
»	NULL
.	NULL

--	NULL
ig	NULL
:	NULL
«	NULL
om	NULL
@	NULL
-	NULL
--	NULL
@	NULL
@	NULL
a	NULL
B	NULL
100	NULL
[	NULL
A	NULL
Uninduced	NULL
80	NULL
M	NULL
rma	NULL
z	NULL
&	NULL
tNFo	NULL
:	NULL
6	NULL
2	NULL
60	NULL
od	NULL
_I	NULL
£	NULL
t	NULL
40	NULL
o	NULL
be	NULL
**	NULL
20	NULL
{	NULL
HIV	NULL
_	NULL
HIV	NULL
_	NULL
SV2	NULL
SVi	NULL
SsV5B	NULL
P2	NULL
(	NULL
2	NULL
)	NULL
«	NULL
B	NULL
(	NULL
3	NULL
)	NULL
P1	NULL
(	NULL
3	NULL
)	NULL
P5	NULL
(	NULL
4	NULL
)	NULL
+TAT	NULL
PLASMID	NULL
PMA	NULL
:	NULL
5.3	NULL
o	NULL
5.6	NULL
o	NULL
7.0	NULL
264	NULL
28.8	NULL
-	NULL
0.7	NULL
3	NULL
TNFo	NULL
:	NULL
1.4	NULL
_	NULL
1.0	NULL
3.3	NULL
-	NULL
0.5	NULL
_	NULL
3.0	NULL
7	NULL
7.9	NULL
0	NULL
_	NULL
0.7	NULL
by	NULL
using	NULL
PCR	NULL
primers	NULL
that	NULL
were	NULL
5°	NULL
end	NULL
labeled	NULL
with	NULL
[	NULL
y-	NULL
>	NULL
P	NULL
]	NULL
JATP	NULL
(	NULL
ICN	NULL
)	NULL
and	NULL
5.0	NULL
U	NULL
of	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
Pharmacia	NULL
)	NULL
for	NULL
1	NULL
h.	NULL
Markers	NULL
(	NULL
plasmid	NULL
pAT1S3	NULL
cleaved	NULL
with	NULL
Haelll	NULL
)	NULL
were	NULL
also	NULL
5	NULL
'	NULL
end	NULL
labeled	NULL
with	NULL
[	NULL
y-	NULL
>	NULL
P	NULL
]	NULL
ATP	NULL
and	NULL
polynucleotide	NULL
kinase	NULL
.	NULL

The	NULL
sequences	NULL
(	NULL
42	NULL
)	NULL
of	NULL
the	NULL
TNF	NULL
primers	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
5	NULL
'	NULL
primer	NULL
:	NULL
5-CCCTCAAGCTGAGGGGCAGCTCCAG-3	NULL
'	NULL
2175	NULL
2199	NULL
3	NULL
'	NULL
primer	NULL
:	NULL
3'-GTCCAGATGAAACCCTAGTAACGGG-S	NULL
'	NULL
2587	NULL
2611	NULL
Northern	NULL
(	NULL
RNA	NULL
)	NULL
blot	NULL
analysis	NULL
.	NULL

Intracellular	NULL
HIV-1	NULL
RNA	NULL
was	NULL
determined	NULL
by	NULL
analysis	NULL
of	NULL
HIV-l-specific	NULL
sequences	NULL
present	NULL
in	NULL
total	NULL
U937	NULL
cellular	NULL
RNA	NULL
isolated	NULL
at	NULL
specific	NULL
times	NULL
after	NULL
initial	NULL
HIV-1	NULL
infection	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
was	NULL
electro-phoresed	NULL
in	NULL
a	NULL
1.0	NULL
%	NULL
formaldehyde	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
nitro-cellulose	NULL
,	NULL
and	NULL
probed	NULL
with	NULL
an	NULL
a	NULL
«	NULL
-	NULL
>	NULL
``	NULL
P-labeled	NULL
nick-translated	NULL
HB1O0	NULL
probe	NULL
,	NULL
a	NULL
12.5-kilobase	NULL
probe	NULL
that	NULL
extends	NULL
over	NULL
the	NULL
entire	NULL
length	NULL
of	NULL
the	NULL
HIV	NULL
genome	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
)	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
air	NULL
dried	NULL
and	NULL
exposed	NULL
to	NULL
Kodak	NULL
X-Omat	NULL
film	NULL
at	NULL
-70°C	NULL
.	NULL

RESULTS	NULL
Stimulation	NULL
of	NULL
TNF-a	NULL
«	NULL
expression	NULL
in	NULL
HIV-1-infected	NULL
cells	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
effects	NULL
of	NULL
HIV	NULL
infection	NULL
on	NULL
TNF	NULL
expression	NULL
,	NULL
oligonucleotide	NULL
primers	NULL
specific	NULL
for	NULL
the	NULL
fourth	NULL
exon	NULL
of	NULL
TNF-a	NULL
(	NULL
42	NULL
)	NULL
were	NULL
used	NULL
in	NULL
a	NULL
PCR	NULL
mRNA	NULL
phenotyping	NULL
procedure	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
to	NULL
characterize	NULL
the	NULL
amount	NULL
of	NULL
TNF-a	NULL
mRNA	NULL
v-_P	NULL
T	NULL
uP	NULL
t	NULL
w	NULL
Poof	NULL
@	NULL
P	NULL
T	NULL
a	NULL
'	NULL
P	NULL
If	NULL
<	NULL
»	NULL
«	NULL
o	NULL
ap	NULL
a*	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Effects	NULL
of	NULL
PMA	NULL
and	NULL
TNF-a	NULL
induction	NULL
on	NULL
various	NULL
hybrid	NULL
promoters	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
transfected	NULL
,	NULL
by	NULL
electroporation	NULL
,	NULL
with	NULL
each	NULL
of	NULL
the	NULL
constructs	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

The	NULL
transfected	NULL
cells	NULL
were	NULL
induced	NULL
with	NULL
PMA	NULL
(	NULL
25	NULL
ng/ml	NULL
)	NULL
or	NULL
TNF-a	NULL
(	NULL
100	NULL
U/ml	NULL
!	NULL
)	NULL

at	NULL
20	NULL
h	NULL
after	NULL
transfection	NULL
and	NULL
harvested	NULL
24	NULL
h	NULL
after	NULL
induction	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
then	NULL
prepared	NULL
for	NULL
CAT	NULL
assays	NULL
.	NULL

Lysates	NULL
(	NULL
30	NULL
ug	NULL
)	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
constructs	NULL
HIV/CAT	NULL
,	NULL
SV2CAT	NULL
,	NULL
SV	NULL
5g	NULL
,	NULL
P1	NULL
(	NULL
3	NULL
)	NULL
/	NULL
CAT	NULL
,	NULL
and	NULL
P5	NULL
(	NULL
4	NULL
)	NULL
/CAT	NULL
were	NULL
assayed	NULL
for	NULL
3	NULL
h.	NULL
Lysates	NULL
(	NULL
20	NULL
pug	NULL
)	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
constructs	NULL
HIV/CAT	NULL
(	NULL
+TAT	NULL
)	NULL
,	NULL
P2	NULL
(	NULL
2	NULL
)	NULL
/CAT	NULL
,	NULL
and	NULL
«	NULL
B	NULL
(	NULL
3	NULL
)	NULL
/CAT	NULL
were	NULL
assayed	NULL
for	NULL
15	NULL
min	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Autoradiograph	NULL
of	NULL
the	NULL
CAT	NULL
assay	NULL
;	NULL
(	NULL
B	NULL
)	NULL
percent	NULL
acetylation	NULL
of	NULL
each	NULL
sample	NULL
.	NULL

Relative	NULL
induction	NULL
of	NULL
each	NULL
treatment	NULL
is	NULL
indicated	NULL
below	NULL
the	NULL
graph	NULL
and	NULL
is	NULL
calculated	NULL
by	NULL
dividing	NULL
percent	NULL
conversion	NULL
in	NULL
the	NULL
treated	NULL
sample	NULL
by	NULL
the	NULL
percent	NULL
conversion	NULL
in	NULL
the	NULL
untreated	NULL
sample	NULL
.	NULL

Percent	NULL
conversion	NULL
in	NULL
uninduced	NULL
samples	NULL
:	NULL
HIV	NULL
,	NULL
8.0	NULL
;	NULL
HIV+TAT	NULL
,	NULL
89.0	NULL
;	NULL
SV2	NULL
,	NULL
5.9	NULL
;	NULL
SV1	NULL
,	NULL
0.2	NULL
;	NULL
SV	NULL
5B	NULL
,	NULL
0.3	NULL
;	NULL
P2	NULL
(	NULL
2	NULL
)	NULL
,	NULL
2.6	NULL
;	NULL
«	NULL
B	NULL
(	NULL
3	NULL
)	NULL
,	NULL
2.3	NULL
;	NULL
P1	NULL
(	NULL
3	NULL
)	NULL
,	NULL
0.3	NULL
;	NULL
P5	NULL
(	NULL
4	NULL
)	NULL
,	NULL
0.3	NULL
.	NULL

Bar	NULL
symbols	NULL
:	NULL
&	NULL
,	NULL
untreated	NULL
;	NULL
M	NULL
,	NULL
PMA	NULL
treated	NULL
;	NULL
E	NULL
,	NULL
TNF-a	NULL
treated	NULL
.	NULL

produced	NULL
in	NULL
U937	NULL
cells	NULL
and	NULL
chronically	NULL
HIV	NULL
infected	NULL
U9-HIB	NULL
cells	NULL
,	NULL
both	NULL
before	NULL
and	NULL
after	NULL
coinfection	NULL
with	NULL
the	NULL
Sendai	NULL
paramyxovirus	NULL
.	NULL

Untreated	NULL
U937	NULL
cells	NULL
did	NULL
not	NULL
spontaneously	NULL
express	NULL
significant	NULL
amounts	NULL
of	NULL
TNF-a	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
whereas	NULL
chronically	NULL
HIV	NULL
infected	NULL
U9-IIIB	NULL
cells	NULL
constitu-tively	NULL
produced	NULL
a	NULL
low	NULL
level	NULL
of	NULL
TNF	NULL
RNA	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Sendai	NULL
virus	NULL
infection	NULL
of	NULL
both	NULL
cell	NULL
types	NULL
increased	NULL
the	NULL
steady-state	NULL
levels	NULL
of	NULL
TNF-a	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
.	NULL

In	NULL
multiple	NULL
experiments	NULL
,	NULL
the	NULL
induced	NULL
U9-IIIB	NULL
cells	NULL
produced	NULL
5	NULL
to	NULL
10	NULL
times	NULL
more	NULL
TNF-	NULL
«	NULL
mRNA	NULL
than	NULL
did	NULL
Sendai	NULL
virus-infected	NULL
U937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
TNF-a	NULL
gene	NULL
expression	NULL
was	NULL
more	NULL
inducible	NULL
in	NULL
cells	NULL
.	NULL

Primers	NULL
to	NULL
the	NULL
glyceraldehyde	NULL
3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
gene	NULL
were	NULL
used	NULL
as	NULL
an	NULL
internal	NULL
constitutive	NULL
RNA	NULL
control	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
)	NULL
;	NULL
these	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
separately	NULL
,	NULL
since	NULL
GAPDH	NULL
amplification	NULL
interfered	NULL
with	NULL
the	NULL
TNF	NULL
amplification	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
constant	NULL
amount	NULL
of	NULL
SV2CAT	NULL
DNA	NULL
(	NULL
107°	NULL
pg	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
and	NULL
coamplified	NULL
with	NULL
TNF	NULL
as	NULL
an	NULL
external	NULL
standard	NULL
for	NULL
quantifi-cation	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
;	NULL
no	NULL
interference	NULL
with	NULL
the	NULL
TNF	NULL
amplification	NULL
was	NULL
observed	NULL
with	NULL
the	NULL
SV2CAT	NULL
control	NULL
.	NULL

When	NULL
reverse	NULL
transcriptase	NULL
was	NULL
excluded	NULL
from	NULL
the	NULL
reaction	NULL
,	NULL
no	NULL
PCR-amplified	NULL
TNF-a	NULL
signals	NULL
were	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lanes	NULL
9	NULL
to	NULL
12	NULL
)	NULL
,	NULL
demonstrating	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
procedure	NULL
.	NULL

This	NULL
pattern	NULL
of	NULL
enhanced	NULL
cytokine	NULL
gene	NULL
transcription	NULL
was	NULL
also	NULL
observed	NULL
with	NULL
other	NULL
monocyte-derived	NULL
cytokines	NULL
such	NULL
as	NULL
IL-1	NULL
and	NULL
IFN-B	NULL
in	NULL
HIV-infected	NULL
cells	NULL
(	NULL
M.	NULL
D'Addario	NULL
,	NULL
A.	NULL
Roulston	NULL
,	NULL
M.	NULL
A.	NULL
Wainberg	NULL
,	NULL
and	NULL
J.	NULL
Hiscott	NULL
,	NULL
submitted	NULL
for	NULL
publication	NULL
)	NULL
.	NULL

Effects	NULL
of	NULL
PMA	NULL
and	NULL
TNF-a	NULL
on	NULL
hybrid	NULL
promoter	NULL
activity	NULL
.	NULL

To	NULL
study	NULL
the	NULL
effects	NULL
of	NULL
TNF-	NULL
«	NULL
treatment	NULL
on	NULL
gene	NULL
expression	NULL
,	NULL
reporter	NULL
plasmids	NULL
containing	NULL
different	NULL
cellular	NULL
and	NULL
viral	NULL
hybrid	NULL
promoters	NULL
were	NULL
derived	NULL
from	NULL
the	NULL
simian	NULL
virus	NULL
(	NULL
SV40	NULL
)	NULL
4730	NULL
LACOSTE	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
plasmids	NULL
.	NULL

-	NULL
HIV/CAT	NULL
HIV/CAT	NULL
SV2CAT	NULL
SV1CAT	NULL
used	NULL
(	NULL
+TAT	NULL
)	NULL
J.	NULL
Viror	NULL
.	NULL

SV5B	NULL
P2	NULL
(	NULL
2	NULL
}	NULL
/CAT	NULL
xB	NULL
(	NULL
3	NULL
)	NULL
/CAT	NULL
P1	NULL
(	NULL
3	NULL
)	NULL
/CAT	NULL
P5	NULL
(	NULL
4	NULL
)	NULL
/CAT	NULL
treatment	NULL
»	NULL
u	NULL
P	NULL
T	NULL
ou	NULL
OP	NULL
OT	NULL
Ou	NULL
OP	NULL
OT	NULL
Ou	NULL
OP	NULL
B	NULL
100	NULL
&	NULL
Uninduced	NULL
80	NULL
H	NULL
pma	NULL
&	NULL
E	NULL
TNFo	NULL
:	NULL
o	NULL
2	NULL
601	NULL
<	NULL
C	NULL
>	NULL
tu	NULL
40	NULL
o	NULL
<	NULL
``	NULL
120	NULL
o	NULL
f	NULL
HIV	NULL
__	NULL
HIV	NULL
SV2	NULL
SVi	NULL
SV5B	NULL
P2	NULL
(	NULL
2	NULL
)	NULL
xB	NULL
(	NULL
3	NULL
)	NULL
P1	NULL
(	NULL
3	NULL
)	NULL
P5	NULL
(	NULL
4	NULL
)	NULL
sTAT	NULL
-	NULL
CAT	NULL
-	NULL
CAT	NULL
PLASMID	NULL
PMA	NULL
3	NULL
18.3	NULL
0.5	NULL
5	NULL
6.3	NULL
28	NULL
0.8	NULL
TNFo	NULL
:	NULL
-	NULL
18.0	NULL
1.4	NULL
29.6	NULL
_	NULL
0.5	NULL
2.0	NULL
100.8	NULL
-	NULL
20.8	NULL
early	NULL
region	NULL
,	NULL
the	NULL
HIV	NULL
LTR	NULL
,	NULL
and	NULL
the	NULL
IFN-B	NULL
regulatory	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

SV2CAT	NULL
contains	NULL
the	NULL
entire	NULL
SV40	NULL
early	NULL
promoter-enhancer	NULL
linked	NULL
to	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
(	NULL
13	NULL
)	NULL
;	NULL
the	NULL
HIV/	NULL
CAT	NULL
plasmid	NULL
encompasses	NULL
the	NULL
complete	NULL
HIV	NULL
LTR	NULL
(	NULL
-350	NULL
to	NULL
+80	NULL
,	NULL
corresponding	NULL
to	NULL
the	NULL
U3	NULL
and	NULL
R	NULL
regions	NULL
)	NULL
(	NULL
24	NULL
)	NULL
;	NULL
and	NULL
SV	NULL
5B	NULL
contains	NULL
the	NULL
entire	NULL
IFN-B	NULL
promoter	NULL
(	NULL
-287	NULL
to	NULL
+19	NULL
)	NULL
,	NULL
linked	NULL
with	NULL
the	NULL
SV40	NULL
enhancer	NULL
for	NULL
increased	NULL
activity	NULL
(	NULL
51	NULL
)	NULL
.	NULL

The	NULL
enhancerless	NULL
SVICAT	NULL
parental	NULL
vector	NULL
was	NULL
used	NULL
to	NULL
generate	NULL
the	NULL
kB	NULL
(	NULL
3	NULL
)	NULL
plasmid	NULL
containing	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
HIV	NULL
enhancer	NULL
element	NULL
(	NULL
-105	NULL
to	NULL
-80	NULL
)	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Different	NULL
regulatory	NULL
domains	NULL
of	NULL
the	NULL
IFN-B	NULL
promoter	NULL
involved	NULL
in	NULL
virus	NULL
inducibility	NULL
were	NULL
also	NULL
subcloned	NULL
into	NULL
SVICAT	NULL
to	NULL
generate	NULL
plasmids	NULL
containing	NULL
three	NULL
copies	NULL
of	NULL
P1	NULL
(	NULL
-79	NULL
to	NULL
-65	NULL
)	NULL
,	NULL
four	NULL
copies	NULL
of	NULL
P5	NULL
(	NULL
-94	NULL
to	NULL
~78	NULL
)	NULL
,	NULL
and	NULL
two	NULL
copies	NULL
of	NULL
P2	NULL
(	NULL
=-64	NULL
to	NULL
=55	NULL
)	NULL
,	NULL
which	NULL
represents	NULL
the	NULL
NF-kB	NULL
recognition	NULL
site	NULL
in	NULL
the	NULL
IFN-B	NULL
promoter	NULL
(	NULL
14	NULL
,	NULL
24	NULL
,	NULL
34	NULL
,	NULL
48	NULL
)	NULL
.	NULL

These	NULL
IFN	NULL
hybrid	NULL
regulatory	NULL
regions	NULL
are	NULL
differentially	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
virus	NULL
induction	NULL
(	NULL
10	NULL
,	NULL
31	NULL
)	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
TNF-	NULL
«	NULL
and	NULL
phorbol	NULL
ester	NULL
on	NULL
hybrid	NULL
promoter	NULL
activity	NULL
were	NULL
examined	NULL
by	NULL
transient	NULL
expression	NULL
in	NULL
monocytic	NULL
U937	NULL
and	NULL
T	NULL
lymphocytic	NULL
Jurkat	NULL
cells	NULL
.	NULL

In	NULL
monocytic	NULL
U937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
phorbol	NULL
ester	NULL
increased	NULL
SV2CAT	NULL
activity	NULL
about	NULL
16-fold	NULL
,	NULL
mediated	NULL
by	NULL
the	NULL
TC-II	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
region	NULL
of	NULL
the	NULL
SV40	NULL
enhancer	NULL
and	NULL
other	NULL
PMA-inducible	NULL
elements	NULL
(	NULL
36	NULL
)	NULL
,	NULL
whereas	NULL
TNF-a	NULL
did	NULL
not	NULL
significantly	NULL
induce	NULL
the	NULL
SV40	NULL
enhancer-promoter	NULL
above	NULL
the	NULL
basal	NULL
level	NULL
of	NULL
activity	NULL
.	NULL

The	NULL
SVICAT	NULL
parental	NULL
vector	NULL
was	NULL
not	NULL
induced	NULL
by	NULL
either	NULL
PMA	NULL
or	NULL
TNF-a	NULL
,	NULL
demonstrating	NULL
the	NULL
enhancer	NULL
dependence	NULL
of	NULL
induction	NULL
.	NULL

The	NULL
entire	NULL
HIV	NULL
LTR	NULL
was	NULL
induced	NULL
about	NULL
fivefold	NULL
by	NULL
PMA	NULL
but	NULL
was	NULL
not	NULL
significantly	NULL
activated	NULL
by	NULL
TNF-a	NULL
.	NULL

Cotrans-	NULL
u	NULL
P	NULL
T.	NULL
u	NULL
P	NULL
T	NULL
u_	NULL
P	NULL
OIT	NULL
ju	NULL
P	NULL
T	NULL
u	NULL
P	NULL
T	NULL
ap	NULL
a	NULL
»	NULL
a	NULL
»	NULL
a	NULL
»	NULL
a	NULL
»	NULL
a	NULL
»	NULL
aP	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Effects	NULL
of	NULL
PMA	NULL
and	NULL
TNF-	NULL
«	NULL
induction	NULL
on	NULL
various	NULL
hybrid	NULL
promoters	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
transfected	NULL
,	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
,	NULL
and	NULL
treated	NULL
as	NULL
for	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Lysates	NULL
(	NULL
30	NULL
ug	NULL
)	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
constructs	NULL
HIV/CAT	NULL
,	NULL
SV2CAT	NULL
,	NULL
SV	NULL
5g	NULL
,	NULL
P1	NULL
(	NULL
3Y/CAT	NULL
,	NULL
and	NULL
P5	NULL
(	NULL
4	NULL
)	NULL
/CAT	NULL
were	NULL
assayed	NULL
for	NULL
3	NULL
h.	NULL
Lysates	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
constructs	NULL
HIV/CAT	NULL
(	NULL
+TAT	NULL
)	NULL
,	NULL
P2	NULL
(	NULL
2Y	NULL
CAT	NULL
,	NULL
and	NULL
«	NULL
B	NULL
(	NULL
3	NULL
)	NULL
/CAT	NULL
were	NULL
assayed	NULL
for	NULL
45	NULL
min	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Autoradiograph	NULL
of	NULL
the	NULL
CAT	NULL
assay	NULL
;	NULL
(	NULL
B	NULL
)	NULL
percent	NULL
acetylation	NULL
and	NULL
relative	NULL
induction	NULL
.	NULL

Percent	NULL
conversion	NULL
in	NULL
uninduced	NULL
samples	NULL
:	NULL
HIV	NULL
,	NULL
0.6	NULL
;	NULL
HIV	NULL
67.0	NULL
;	NULL
SV2	NULL
,	NULL
1.7	NULL
;	NULL
SV1	NULL
,	NULL
0.2	NULL
;	NULL
SV5B	NULL
,	NULL
0.1	NULL
;	NULL
P2	NULL
(	NULL
2	NULL
)	NULL
,	NULL
0.6	NULL
;	NULL
«	NULL
B	NULL
(	NULL
3	NULL
)	NULL
,	NULL
2.9	NULL
;	NULL
P1	NULL
(	NULL
3	NULL
)	NULL
,	NULL
0.9	NULL
;	NULL
P5	NULL
(	NULL
4	NULL
)	NULL
,	NULL
1.2	NULL
.	NULL

Bar	NULL
symbols	NULL
:	NULL
&	NULL
,	NULL
untreated	NULL
;	NULL
MW	NULL
,	NULL
PMA	NULL
treated	NULL
;	NULL
8	NULL
,	NULL
TNF-a	NULL
treated	NULL
.	NULL

fection	NULL
with	NULL
an	NULL
expression	NULL
plasmid	NULL
encoding	NULL
rat-1	NULL
increased	NULL
activity	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
more	NULL
than	NULL
100-fold	NULL
,	NULL
beyond	NULL
the	NULL
linear	NULL
range	NULL
of	NULL
the	NULL
assay	NULL
shown	NULL
.	NULL

When	NULL
the	NULL
HIV	NULL
enhancer	NULL
alone	NULL
was	NULL
analyzed	NULL
in	NULL
plasmid	NULL
kB	NULL
(	NULL
3	NULL
)	NULL
,	NULL
TNF-	NULL
«	NULL
increased	NULL
promoter	NULL
activity	NULL
8-fold	NULL
,	NULL
compared	NULL
with	NULL
a	NULL
29-fold	NULL
induction	NULL
with	NULL
PMA	NULL
.	NULL

Several	NULL
significant	NULL
differences	NULL
were	NULL
observed	NULL
when	NULL
the	NULL
effects	NULL
of	NULL
TNF-a	NULL
and	NULL
PMA	NULL
were	NULL
examined	NULL
on	NULL
the	NULL
inducible	NULL
IFN-B	NULL
promoter	NULL
.	NULL

The	NULL
IFN-B	NULL
promoter	NULL
was	NULL
not	NULL
responsive	NULL
to	NULL
either	NULL
treatment	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
and	NULL
even	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
SV40	NULL
enhancer	NULL
linked	NULL
to	NULL
the	NULL
IFN-B	NULL
promoter	NULL
only	NULL
moderately	NULL
increased	NULL
gene	NULL
activity	NULL
after	NULL
PMA	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
supports	NULL
previous	NULL
observations	NULL
that	NULL
the	NULL
IFN-B	NULL
promoter	NULL
contains	NULL
negative	NULL
regulatory	NULL
elements	NULL
capable	NULL
of	NULL
silencing	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
SV40	NULL
enhancer	NULL
(	NULL
15	NULL
,	NULL
21	NULL
,	NULL
51	NULL
,	NULL
54	NULL
)	NULL
.	NULL

Individual	NULL
IFN-B	NULL
domains	NULL
were	NULL
also	NULL
examined	NULL
;	NULL
plasmids	NULL
containing	NULL
the	NULL
P1	NULL
and	NULL
P5	NULL
regions	NULL
were	NULL
not	NULL
induced	NULL
by	NULL
PMA	NULL
or	NULL
TNF-a	NULL
«	NULL
,	NULL
reflecting	NULL
the	NULL
virus-inducible	NULL
specificity	NULL
of	NULL
these	NULL
regions	NULL
(	NULL
10	NULL
,	NULL
16	NULL
,	NULL
31	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
P2	NULL
(	NULL
2	NULL
)	NULL
CAT	NULL
plasmid	NULL
was	NULL
induced	NULL
26-	NULL
and	NULL
7-fold	NULL
by	NULL
PMA	NULL
and	NULL
TNF-a	NULL
,	NULL
respectively	NULL
;	NULL
these	NULL
effects	NULL
were	NULL
virtually	NULL
identical	NULL
to	NULL
the	NULL
results	NULL
observed	NULL
with	NULL
kB	NULL
(	NULL
3	NULL
)	NULL
.	NULL

These	NULL
experiments	NULL
confirm	NULL
that	NULL
the	NULL
«	NULL
B-contain-ing	NULL
elements	NULL
of	NULL
the	NULL
HIV	NULL
enhancer	NULL
and	NULL
the	NULL
IFN-B	NULL
promoter	NULL
are	NULL
equivalent	NULL
regulatory	NULL
elements	NULL
when	NULL
analyzed	NULL
individually	NULL
(	NULL
14	NULL
,	NULL
24	NULL
,	NULL
34	NULL
,	NULL
48	NULL
)	NULL
and	NULL
in	NULL
U937	NULL
cells	NULL
are	NULL
differentially	NULL
induced	NULL
by	NULL
phorbol	NULL
esters	NULL
and	NULL
TNF-	NULL
«	NULL
.	NULL

Despite	NULL
the	NULL
inducibility	NULL
of	NULL
these	NULL
domains	NULL
,	NULL
activities	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
and	NULL
the	NULL
IFN-B	NULL
promoter	NULL
were	NULL
not	NULL
increased	NULL
above	NULL
a	NULL
basal	NULL
level	NULL
of	NULL
activity	NULL
by	NULL
TNF-a	NULL
treatment	NULL
.	NULL

The	NULL
same	NULL
constructs	NULL
were	NULL
analyzed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

In	NULL
this	NULL
cellular	NULL
background	NULL
,	NULL
a	NULL
major	NULL
difference	NULL
in	NULL
promoter	NULL
activity	NULL
was	NULL
observed	NULL
;	NULL
P2	NULL
(	NULL
2	NULL
)	NULL
and	NULL
kB	NULL
(	NULL
3	NULL
)	NULL
plasmids	NULL
were	NULL
strongly	NULL
induced	NULL
(	NULL
up	NULL
to	NULL
100-fold	NULL
)	NULL
by	NULL
PMA	NULL
and	NULL
TNF-a	NULL
treatments	NULL
.	NULL

Most	NULL
importantly	NULL
,	NULL
activity	NULL
of	NULL
the	NULL
intact	NULL
HIV	NULL
LTR	NULL
was	NULL
also	NULL
induced	NULL
about	NULL
20-fold	NULL
by	NULL
TNF-a	NULL
treatment	NULL
,	NULL
although	NULL
PMA	NULL
induction	NULL
was	NULL
still	NULL
about	NULL
4-fold	NULL
higher	NULL
.	NULL

Plas-	NULL
Vor	NULL
.	NULL

64	NULL
,	NULL
1990	NULL
A	NULL
Competitor	NULL
HiIVenh	NULL
P2	NULL
(	NULL
2	NULL
)	NULL
HIVmut	NULL
Treatment	NULL
u_	NULL
P.	NULL
I	NULL
u	NULL
P	NULL
T	NULL
u	NULL
.	NULL

-P	NULL
T	NULL
u_	NULL
P	NULL
I	NULL
-__-	NULL
Uw	NULL
ti	NULL
@	NULL
-1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
.	NULL

-	NULL
%	NULL
9	NULL
10	NULL
11	NULL
12	NULL
B	NULL
Competitor	NULL
HiVenh	NULL
P2	NULL
(	NULL
2	NULL
)	NULL
HiVmut	NULL
Treatment	NULL
u	NULL
P	NULL
.T	NULL
u	NULL
p-	NULL
-T	NULL
u	NULL
P	NULL
-I	NULL
u	NULL
P	NULL
--	NULL
I	NULL
-	NULL
-	NULL
UW	NULL
be	NULL
be	NULL
=a	NULL
Cb	NULL
tne	NULL
amid	NULL
Gnas	NULL
1	NULL
2	NULL
$	NULL
4	NULL
_	NULL
5	NULL
6	NULL
7	NULL
§	NULL
9	NULL
10	NULL
11	NULL
12	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Effects	NULL
of	NULL
TNF-	NULL
«	NULL
and	NULL
PMA	NULL
treatments	NULL
on	NULL
binding	NULL
of	NULL
«	NULL
B-like	NULL
proteins	NULL
in	NULL
U937	NULL
(	NULL
A	NULL
)	NULL
and	NULL
Jurkat	NULL
(	NULL
B	NULL
)	NULL
cell	NULL
extracts	NULL
.	NULL

WCE	NULL
were	NULL
prepared	NULL
from	NULL
uninduced	NULL
and	NULL
from	NULL
PMA-	NULL
and	NULL
TNF-	NULL
«	NULL
-induced	NULL
U937	NULL
and	NULL
Jurkat	NULL
cells	NULL
;	NULL
15	NULL
and	NULL
10	NULL
ug	NULL
of	NULL
U937	NULL
and	NULL
Jurkat	NULL
protein	NULL
extracts	NULL
,	NULL
respectively	NULL
,	NULL
were	NULL
tested	NULL
for	NULL
binding	NULL
activity	NULL
to	NULL
an	NULL
HIV	NULL
enhancer	NULL
probe	NULL
(	NULL
HIVenh	NULL
;	NULL
0.2	NULL
ng	NULL
)	NULL
.	NULL

Extracts	NULL
were	NULL
also	NULL
competed	NULL
with	NULL
a	NULL
125-fold	NULL
excess	NULL
of	NULL
competitor	NULL
(	NULL
25	NULL
ng	NULL
)	NULL
,	NULL
shown	NULL
above	NULL
the	NULL
lanes	NULL
.	NULL

The	NULL
arrowhead	NULL
marks	NULL
the	NULL
kB	NULL
protein-DNA	NULL
complexes	NULL
.	NULL

HIV	NULL
mut	NULL
,	NULL
HIV	NULL
enhancer	NULL
containing	NULL
a	NULL
clustered	NULL
mutation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
.	NULL

mids	NULL
such	NULL
as	NULL
SVICAT	NULL
,	NULL
SVSB	NULL
,	NULL
P1	NULL
(	NULL
3	NULL
)	NULL
,	NULL
and	NULL
P5	NULL
(	NULL
4	NULL
)	NULL
did	NULL
not	NULL
respond	NULL
to	NULL
either	NULL
inducer	NULL
,	NULL
whereas	NULL
SV2CAT	NULL
was	NULL
strongly	NULL
induced	NULL
by	NULL
both	NULL
compounds	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
T	NULL
cells	NULL
respond	NULL
more	NULL
effectively	NULL
to	NULL
the	NULL
transcription-activat-ing	NULL
effects	NULL
of	NULL
TNF-	NULL
.	NULL

Induction	NULL
of	NULL
NF-B	NULL
binding	NULL
by	NULL
PMA	NULL
and	NULL
TNF-	NULL
«	NULL
.	NULL

WCE	NULL
were	NULL
prepared	NULL
from	NULL
untreated	NULL
or	NULL
treated	NULL
U937	NULL
and	NULL
Jurkat	NULL
cells	NULL
to	NULL
examine	NULL
protein-DNA	NULL
interactions	NULL
within	NULL
the	NULL
HIV	NULL
enhancer	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

In	NULL
U937	NULL
cells	NULL
,	NULL
PMA	NULL
induced	NULL
binding	NULL
of	NULL
a	NULL
factor	NULL
to	NULL
the	NULL
HIV	NULL
enhancer	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
;	NULL
TNF-a	NULL
also	NULL
induced	NULL
formation	NULL
of	NULL
a	NULL
similar	NULL
protein-DNA	NULL
complex	NULL
,	NULL
EFFECT	NULL
OF	NULL
TNF-	NULL
«	NULL
ON	NULL
HIV	NULL
AND	NULL
IFN-8	NULL
GENE	NULL
EXPRESSION	NULL
4731	NULL
but	NULL
fivefold	NULL
less	NULL
complex	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

SA	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

The	NULL
induced	NULL
complexes	NULL
were	NULL
competed	NULL
for	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
homologous	NULL
HIV	NULL
enhancer	NULL
sequence	NULL
and	NULL
by	NULL
the	NULL
P2	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lanes	NULL
4	NULL
to	NULL
9	NULL
)	NULL
,	NULL
whereas	NULL
an	NULL
HIV	NULL
enhancer	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
clustered	NULL
mutation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
was	NULL
unable	NULL
to	NULL
compete	NULL
for	NULL
complex	NULL
formation	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lanes	NULL
10	NULL
to	NULL
12	NULL
)	NULL
,	NULL
demonstrating	NULL
the	NULL
specificity	NULL
of	NULL
binding	NULL
.	NULL

When	NULL
Jurkat	NULL
extracts	NULL
were	NULL
analyzed	NULL
,	NULL
identical	NULL
inducible	NULL
complexes	NULL
were	NULL
also	NULL
formed	NULL
after	NULL
PMA	NULL
and	NULL
TNF-	NULL
«	NULL
treatments	NULL
,	NULL
with	NULL
the	NULL
significant	NULL
difference	NULL
that	NULL
TNF-a	NULL
was	NULL
as	NULL
potent	NULL
an	NULL
inducer	NULL
of	NULL
complex	NULL
formation	NULL
in	NULL
T	NULL
cells	NULL
as	NULL
was	NULL
phorbol	NULL
ester	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
.	NULL

Competition	NULL
assays	NULL
again	NULL
demonstrated	NULL
that	NULL
complex	NULL
formation	NULL
was	NULL
dependent	NULL
on	NULL
intact	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
within	NULL
the	NULL
HIV	NULL
enhancer	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lanes	NULL
10	NULL
to	NULL
12	NULL
)	NULL
.	NULL

To	NULL
further	NULL
confirm	NULL
that	NULL
the	NULL
HIV	NULL
enhancer	NULL
and	NULL
the	NULL
P2	NULL
domain	NULL
interacted	NULL
with	NULL
the	NULL
same	NULL
NF-kB	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lanes	NULL
4	NULL
to	NULL
9	NULL
)	NULL
,	NULL
the	NULL
DNA-binding	NULL
studies	NULL
were	NULL
repeated	NULL
with	NULL
use	NULL
of	NULL
a	NULL
P2	NULL
oligonucleotide	NULL
probe	NULL
,	NULL
and	NULL
results	NULL
identical	NULL
to	NULL
those	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
were	NULL
obtained	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
demonstrated	NULL
a	NULL
coordinate	NULL
activation	NULL
of	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
and	NULL
transcriptional	NULL
induction	NULL
of	NULL
<	NULL
B-containing	NULL
plasmids	NULL
in	NULL
monocytic	NULL
and	NULL
T	NULL
lymphoid	NULL
cells	NULL
.	NULL

Stimulation	NULL
of	NULL
HIV-1	NULL
multiplication	NULL
in	NULL
T	NULL
cells	NULL
by	NULL
TNF-a	NULL
.	NULL

Despite	NULL
the	NULL
correlation	NULL
between	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
and	NULL
induction	NULL
of	NULL
<	NULL
B-containing	NULL
plasmids	NULL
by	NULL
PMA	NULL
and	NULL
TNF-a	NULL
,	NULL
the	NULL
previous	NULL
results	NULL
also	NULL
demonstrated	NULL
that	NULL
in	NULL
U937	NULL
cells	NULL
,	NULL
the	NULL
HIV	NULL
LTR	NULL
was	NULL
not	NULL
significantly	NULL
activated	NULL
above	NULL
the	NULL
basal	NULL
level	NULL
of	NULL
activity	NULL
by	NULL
TNF-a	NULL
.	NULL

To	NULL
directly	NULL
examine	NULL
the	NULL
effect	NULL
of	NULL
TNF-a	NULL
on	NULL
the	NULL
kinetics	NULL
of	NULL
de	NULL
novo	NULL
HIV-1	NULL
infection	NULL
,	NULL
U937	NULL
and	NULL
Jurkat	NULL
cells	NULL
were	NULL
infected	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TNF-a	NULL
.	NULL

Spread	NULL
of	NULL
HIV-1	NULL
through	NULL
U937	NULL
cells	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
p24	NULL
antigen	NULL
immunofluorescence	NULL
,	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
TNF-a	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

When	NULL
viral	NULL
RNA	NULL
was	NULL
measured	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
,	NULL
no	NULL
difference	NULL
in	NULL
the	NULL
accumulation	NULL
of	NULL
intracellular	NULL
viral	NULL
RNA	NULL
was	NULL
observed	NULL
between	NULL
untreated	NULL
and	NULL
TNF-a	NULL
«	NULL
-treated	NULL
U937	NULL
cells	NULL
during	NULL
days	NULL
2	NULL
to	NULL
10	NULL
p.i	NULL
.	NULL

(	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
8	NULL
)	NULL
.	NULL

Significant	NULL
cytopathology	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
HIV-l-infected	NULL
U937	NULL
cells	NULL
(	NULL
J.	NULL
Lacoste	NULL
,	NULL
unpublished	NULL
ob-servations	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
TNF-a	NULL
dramatically	NULL
stimulated	NULL
the	NULL
kinetics	NULL
of	NULL
de	NULL
novo	NULL
HIV-1	NULL
infection	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
and	NULL
viral	NULL
RNA	NULL
production	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
lanes	NULL
9	NULL
to	NULL
18	NULL
)	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
TNF-	NULL
«	NULL
-treated	NULL
Jurkat	NULL
cells	NULL
,	NULL
viral	NULL
RNA	NULL
accumulated	NULL
rapidly	NULL
and	NULL
was	NULL
easily	NULL
detectable	NULL
at	NULL
4	NULL
days	NULL
p.i	NULL
.	NULL

,	NULL
whereas	NULL
viral	NULL
RNA	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
untreated	NULL
HIV-l-infected	NULL
Jurkat	NULL
cells	NULL
until	NULL
8	NULL
days	NULL
p.i	NULL
.	NULL

(	NULL
Fig	NULL
.	NULL

6C	NULL
;	NULL
compare	NULL
lanes	NULL
10	NULL
and	NULL
13	NULL
)	NULL
.	NULL

Lytic	NULL
destruction	NULL
of	NULL
the	NULL
TNF-	NULL
«	NULL
-treated	NULL
,	NULL
HIV-l-infected	NULL
Jurkat	NULL
cells	NULL
occurred	NULL
between	NULL
8	NULL
and	NULL
10	NULL
days	NULL
p.i	NULL
.	NULL

and	NULL
probably	NULL
accounts	NULL
for	NULL
the	NULL
degradation	NULL
of	NULL
viral	NULL
RNA	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
lane	NULL
16	NULL
)	NULL
.	NULL

In	NULL
untreated	NULL
cells	NULL
,	NULL
cell	NULL
lysis	NULL
was	NULL
observed	NULL
at	NULL
14	NULL
to	NULL
16	NULL
days	NULL
p.i	NULL
.	NULL

(	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
lane	NULL
18	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
TNF-a	NULL
treatment	NULL
of	NULL
Jurkat	NULL
cells	NULL
accelerated	NULL
viral	NULL
RNA	NULL
synthesis	NULL
and	NULL
lytic	NULL
destruction	NULL
of	NULL
the	NULL
cell	NULL
population	NULL
,	NULL
whereas	NULL
no	NULL
TNF-a	NULL
effect	NULL
was	NULL
observed	NULL
in	NULL
U937	NULL
cells	NULL
with	NULL
respect	NULL
to	NULL
either	NULL
viral	NULL
RNA	NULL
production	NULL
or	NULL
cell	NULL
death	NULL
.	NULL

DISCUSSION	NULL
This	NULL
study	NULL
has	NULL
characterized	NULL
three	NULL
important	NULL
aspects	NULL
of	NULL
the	NULL
interactions	NULL
between	NULL
the	NULL
cytokine	NULL
TNF-a	NULL
and	NULL
HIV	NULL
pathogenesis	NULL
.	NULL

We	NULL
have	NULL
observed	NULL
that	NULL
HIV-infected	NULL
monocytic	NULL
U9-IIIB	NULL
cells	NULL
can	NULL
be	NULL
superinduced	NULL
for	NULL
TNF-	NULL
«	NULL
mRNA	NULL
production	NULL
by	NULL
a	NULL
secondary	NULL
virus	NULL
infection	NULL
.	NULL

Sendai	NULL
virus	NULL
infection	NULL
was	NULL
chosen	NULL
as	NULL
an	NULL
inducing	NULL
agent	NULL
since	NULL
its	NULL
cytokine-activating	NULL
potential	NULL
has	NULL
been	NULL
characterized	NULL
previously	NULL
in	NULL
the	NULL
parental	NULL
U937	NULL
cells	NULL
(	NULL
24	NULL
)	NULL
.	NULL

TNF-a	NULL
RNA	NULL
was	NULL
produced	NULL
at	NULL
a	NULL
low	NULL
4732	NULL
LACOSTE	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
%	NULL
p24	NULL
Positive	NULL
Cells	NULL
C	NULL
Cells	NULL
:	NULL
U937	NULL
J.	NULL
ViroL	NULL
.	NULL

40	NULL
Jurkat	NULL
30	NULL
20	NULL
4	NULL
0	NULL
2	NULL
4	NULL
6	NULL
8	NULL
10	NULL
12	NULL
Day	NULL
:	NULL
2	NULL
4	NULL
6	NULL
10	NULL
Treatment	NULL
:	NULL
u_	NULL
T	NULL
u	NULL
I	NULL
u	NULL
.T	NULL
u	NULL
T.	NULL
'	NULL
u	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
-+	NULL
9.0kb	NULL
-+4.5kb	NULL
-+	NULL
2.0kb	NULL
15	NULL
16	NULL
17	NULL
18	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Effect	NULL
of	NULL
TNF	NULL
treatment	NULL
on	NULL
HIV-1	NULL
infection	NULL
of	NULL
U937	NULL
and	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
number	NULL
of	NULL
p24	NULL
antigen-positive	NULL
cells	NULL
was	NULL
measured	NULL
in	NULL
U937	NULL
(	NULL
A	NULL
)	NULL
and	NULL
Jurkat	NULL
(	NULL
B	NULL
)	NULL
cells	NULL
by	NULL
indirect	NULL
immunofluorescence	NULL
at	NULL
different	NULL
times	NULL
after	NULL
infection	NULL
.	NULL

TNF-a	NULL
(	NULL
100	NULL
U/ml	NULL
!	NULL
)	NULL

was	NULL
added	NULL
at	NULL
24	NULL
h	NULL
p.i	NULL
.	NULL

(	NULL
@	NULL
)	NULL
.	NULL

C	NULL
,	NULL
Untreated	NULL
cells	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
intracellular	NULL
RNA	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
from	NULL
U937	NULL
cells	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
8	NULL
)	NULL
or	NULL
Jurkat	NULL
cells	NULL
(	NULL
lanes	NULL
9	NULL
to	NULL
18	NULL
)	NULL
was	NULL
isolated	NULL
from	NULL
untreated	NULL
(	NULL
u	NULL
)	NULL
or	NULL
TNF-treated	NULL
(	NULL
T	NULL
)	NULL
cells	NULL
at	NULL
different	NULL
days	NULL
after	NULL
HIV-1	NULL
infection	NULL
(	NULL
indicated	NULL
above	NULL
the	NULL
gel	NULL
)	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
9.0-	NULL
,	NULL
4.5-	NULL
,	NULL
and	NULL
2.0-kilobase	NULL
(	NULL
kb	NULL
)	NULL
viral	NULL
RNA	NULL
species	NULL
are	NULL
indicated	NULL
.	NULL

Lanes	NULL
1	NULL
to	NULL
10	NULL
were	NULL
exposed	NULL
to	NULL
film	NULL
for	NULL
16	NULL
h	NULL
and	NULL
lanes	NULL
11	NULL
to	NULL
18	NULL
were	NULL
exposed	NULL
to	NULL
film	NULL
for	NULL
2	NULL
h	NULL
to	NULL
illustrate	NULL
the	NULL
patterns	NULL
of	NULL
viral	NULL
RNA	NULL
migration	NULL
.	NULL

constitutive	NULL
level	NULL
in	NULL
HIV-infected	NULL
cells	NULL
,	NULL
but	NULL
after	NULL
secondary	NULL
virus	NULL
infection	NULL
,	NULL
U9-IIIB	NULL
cells	NULL
produced	NULL
higher	NULL
levels	NULL
of	NULL
TNF-	NULL
«	NULL
mRNA	NULL
and	NULL
secreted	NULL
more	NULL
TNF-a	NULL
,	NULL
as	NULL
detected	NULL
by	NULL
radioimmunoassay	NULL
,	NULL
than	NULL
did	NULL
similarly	NULL
induced	NULL
U937	NULL
cells	NULL
(	NULL
M.	NULL
D'Addario	NULL
et	NULL
al	NULL
.	NULL

,	NULL
submitted	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
superinduction	NULL
of	NULL
transcript	NULL
levels	NULL
was	NULL
observed	NULL
with	NULL
other	NULL
cytokine	NULL
genes	NULL
after	NULL
coinfection	NULL
,	NULL
suggesting	NULL
that	NULL
multiple	NULL
cytokine	NULL
regulatory	NULL
pathways	NULL
may	NULL
be	NULL
altered	NULL
by	NULL
chronic	NULL
HIV	NULL
infection	NULL
.	NULL

Dysregulation	NULL
of	NULL
coordinately	NULL
regulated	NULL
cytokine	NULL
pathways	NULL
(	NULL
20	NULL
,	NULL
38	NULL
)	NULL
will	NULL
likely	NULL
have	NULL
direct	NULL
effects	NULL
on	NULL
HIV	NULL
provirus	NULL
reactivation	NULL
and	NULL
viral	NULL
pathogenesis	NULL
,	NULL
since	NULL
certain	NULL
cytokines	NULL
(	NULL
TNF	NULL
and	NULL
IL-1	NULL
)	NULL
are	NULL
stimulatory	NULL
signals	NULL
for	NULL
HIV	NULL
transcription	NULL
(	NULL
4	NULL
,	NULL
9	NULL
,	NULL
12	NULL
,	NULL
28	NULL
,	NULL
37	NULL
)	NULL
.	NULL

In	NULL
support	NULL
of	NULL
these	NULL
observations	NULL
,	NULL
sera	NULL
from	NULL
patients	NULL
with	NULL
acquired	NULL
immunodeficiency	NULL
syndrome	NULL
(	NULL
AIDS	NULL
)	NULL
often	NULL
have	NULL
higher	NULL
circulating	NULL
TNF	NULL
levels	NULL
,	NULL
and	NULL
increased	NULL
half-life	NULL
of	NULL
TNF-	NULL
«	NULL
mRNA	NULL
has	NULL
recently	NULL
been	NULL
observed	NULL
in	NULL
mononuclear	NULL
cells	NULL
from	NULL
patients	NULL
with	NULL
AIDS	NULL
(	NULL
49	NULL
,	NULL
50	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
TNF-	NULL
«	NULL
on	NULL
the	NULL
HIV	NULL
LTR	NULL
and	NULL
the	NULL
IFN-B	NULL
regulatory	NULL
regions	NULL
was	NULL
investigated	NULL
by	NULL
transient	NULL
expression	NULL
assays	NULL
in	NULL
monocytic	NULL
U937	NULL
and	NULL
T	NULL
lymphoid	NULL
Jurkat	NULL
cells	NULL
.	NULL

These	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
reporter	NULL
CAT	NULL
plasmids	NULL
linked	NULL
to	NULL
the	NULL
promoter	NULL
regions	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
,	NULL
the	NULL
HIV	NULL
enhancer	NULL
,	NULL
the	NULL
IFN-B	NULL
promoter	NULL
,	NULL
and	NULL
distinct	NULL
regulatory	NULL
domains	NULL
of	NULL
the	NULL
IFN-B	NULL
enhancer	NULL
.	NULL

As	NULL
described	NULL
previously	NULL
,	NULL
TNF-a	NULL
is	NULL
an	NULL
effective	NULL
inducer	NULL
of	NULL
regulatory	NULL
elements	NULL
containing	NULL
NF-kB	NULL
recognition	NULL
sites	NULL
(	NULL
8	NULL
,	NULL
18	NULL
,	NULL
29	NULL
,	NULL
30	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
demonstrate	NULL
here	NULL
that	NULL
the	NULL
relative	NULL
inducibility	NULL
of	NULL
NF-	NULL
«	NULL
B-containing	NULL
elements	NULL
varies	NULL
in	NULL
a	NULL
cell	NULL
type-	NULL
and	NULL
promoter	NULL
context-specific	NULL
manner	NULL
.	NULL

In	NULL
U937	NULL
cells	NULL
,	NULL
phorbol	NULL
ester	NULL
was	NULL
a	NULL
more	NULL
effective	NULL
inducer	NULL
of	NULL
NF-kB	NULL
DNA	NULL
binding	NULL
and	NULL
gene	NULL
activity	NULL
than	NULL
was	NULL
TNF-	NULL
«	NULL
.	NULL

Hybrid	NULL
promoter	NULL
plasmids	NULL
containing	NULL
multimers	NULL
of	NULL
the	NULL
PRDII	NULL
domain	NULL
of	NULL
IFN-B	NULL
[	NULL
p2	NULL
(	NULL
2	NULL
)	NULL
]	NULL
or	NULL
multiple	NULL
copies	NULL
of	NULL
the	NULL
HIV	NULL
enhancer	NULL
[	NULL
kB	NULL
(	NULL
3	NULL
)	NULL
]	NULL
were	NULL
both	NULL
induced	NULL
by	NULL
TNF-a	NULL
and	NULL
PMA	NULL
,	NULL
but	NULL
the	NULL
level	NULL
of	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
and	NULL
DNA	NULL
binding	NULL
was	NULL
about	NULL
fivefold	NULL
lower	NULL
after	NULL
TNF-a	NULL
treatment	NULL
.	NULL

When	NULL
the	NULL
intact	NULL
HIV	NULL
LTR	NULL
and	NULL
IFN-B	NULL
promoters	NULL
were	NULL
compared	NULL
,	NULL
PMA	NULL
but	NULL
not	NULL
TNF-a	NULL
treatment	NULL
induced	NULL
the	NULL
HIV	NULL
LTR	NULL
,	NULL
whereas	NULL
the	NULL
IFN-B	NULL
promoter	NULL
was	NULL
not	NULL
significantly	NULL
activated	NULL
by	NULL
either	NULL
treatment	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
IFN-B	NULL
promoter	NULL
displayed	NULL
a	NULL
dominant	NULL
repressive	NULL
activity	NULL
on	NULL
a	NULL
linked	NULL
SV40	NULL
enhancer	NULL
,	NULL
since	NULL
the	NULL
Vor	NULL
.	NULL

64	NULL
,	NULL
1990	NULL
intact	NULL
SV40	NULL
enhancer	NULL
in	NULL
SV2CAT	NULL
was	NULL
strongly	NULL
inducible	NULL
by	NULL
PMA	NULL
and	NULL
moderately	NULL
inducible	NULL
by	NULL
TNF-a	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
TNF-a	NULL
was	NULL
a	NULL
potent	NULL
inducer	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
activity	NULL
and	NULL
CAT	NULL
activity	NULL
in	NULL
T	NULL
lymphoid	NULL
cells	NULL
;	NULL
TNF-a	NULL
treatment	NULL
also	NULL
induced	NULL
the	NULL
HIV	NULL
LTR	NULL
,	NULL
although	NULL
to	NULL
a	NULL
lower	NULL
level	NULL
than	NULL
observed	NULL
with	NULL
PMA	NULL
treatment	NULL
.	NULL

In	NULL
this	NULL
cell	NULL
type	NULL
,	NULL
a	NULL
strong	NULL
correlation	NULL
between	NULL
gene	NULL
activity	NULL
and	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
was	NULL
also	NULL
observed	NULL
.	NULL

Also	NULL
as	NULL
in	NULL
monocytic	NULL
cells	NULL
,	NULL
the	NULL
IFN-B	NULL
promoter	NULL
was	NULL
completely	NULL
inactive	NULL
and	NULL
silenced	NULL
an	NULL
otherwise	NULL
highly	NULL
inducible	NULL
SV40	NULL
enhancer	NULL
.	NULL

Interestingly	NULL
,	NULL
unique	NULL
regions	NULL
of	NULL
the	NULL
IFN-B	NULL
promoter	NULL
displayed	NULL
distinct	NULL
inducibility	NULL
properties	NULL
:	NULL
the	NULL
PRDII	NULL
domain	NULL
of	NULL
the	NULL
IFN-B	NULL
promoter	NULL
was	NULL
induced	NULL
by	NULL
TNF-	NULL
«	NULL
and	NULL
PMA	NULL
,	NULL
but	NULL
the	NULL
P1	NULL
and	NULL
PS	NULL
regions	NULL
were	NULL
not	NULL
responsive	NULL
.	NULL

Previous	NULL
experiments	NULL
showed	NULL
that	NULL
the	NULL
IFN-B	NULL
promoter	NULL
was	NULL
weakly	NULL
inducible	NULL
by	NULL
TNF-a	NULL
(	NULL
29	NULL
)	NULL
,	NULL
and	NULL
the	NULL
results	NULL
presented	NULL
here	NULL
demonstrate	NULL
that	NULL
this	NULL
effect	NULL
is	NULL
mediated	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
to	NULL
PRDIIL	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
sought	NULL
to	NULL
examine	NULL
the	NULL
consequences	NULL
of	NULL
TNF-a	NULL
treatment	NULL
on	NULL
the	NULL
kinetics	NULL
of	NULL
HIV	NULL
multiplication	NULL
in	NULL
monocytic	NULL
and	NULL
T	NULL
lymphoid	NULL
cells	NULL
.	NULL

Continual	NULL
treatment	NULL
of	NULL
U937	NULL
cells	NULL
with	NULL
TNF-a	NULL
during	NULL
HIV	NULL
infection	NULL
had	NULL
no	NULL
influence	NULL
,	NULL
either	NULL
inhib-itory	NULL
or	NULL
stimulatory	NULL
,	NULL
on	NULL
the	NULL
course	NULL
of	NULL
HIV	NULL
transmission	NULL
as	NULL
measured	NULL
by	NULL
p24	NULL
antigen	NULL
immunofluorescence	NULL
and	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
HIV	NULL
RNA	NULL
accumulation	NULL
.	NULL

This	NULL
result	NULL
suggests	NULL
that	NULL
a	NULL
level	NULL
of	NULL
NF-	NULL
«	NULL
B-independent	NULL
transcription	NULL
from	NULL
the	NULL
HIV	NULL
LTR	NULL
is	NULL
sufficient	NULL
for	NULL
virus	NULL
multiplication	NULL
and	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
demonstration	NULL
that	NULL
the	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
in	NULL
the	NULL
HIV	NULL
LTR	NULL
may	NULL
not	NULL
be	NULL
absolutely	NULL
required	NULL
for	NULL
virus	NULL
infectivity	NULL
(	NULL
32	NULL
)	NULL
.	NULL

In	NULL
T	NULL
cells	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
TNF-	NULL
«	NULL
produced	NULL
a	NULL
dramatic	NULL
increase	NULL
in	NULL
multiplication	NULL
and	NULL
spread	NULL
of	NULL
HIV	NULL
through	NULL
the	NULL
culture	NULL
,	NULL
culminating	NULL
in	NULL
lytic	NULL
destruction	NULL
of	NULL
the	NULL
cell	NULL
population	NULL
by	NULL
8	NULL
days	NULL
,	NULL
as	NULL
compared	NULL
with	NULL
16	NULL
days	NULL
for	NULL
the	NULL
untreated	NULL
,	NULL
HIV-infected	NULL
Jurkat	NULL
cells	NULL
.	NULL

This	NULL
dramatic	NULL
alteration	NULL
in	NULL
the	NULL
time	NULL
course	NULL
of	NULL
HIV	NULL
transmission	NULL
in	NULL
T	NULL
cells	NULL
correlates	NULL
directly	NULL
with	NULL
the	NULL
responsiveness	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
and	NULL
NF-	NULL
«	NULL
kB-containing	NULL
plasmids	NULL
to	NULL
TNF-a	NULL
observed	NULL
in	NULL
the	NULL
transfection	NULL
studies	NULL
.	NULL

In	NULL
vivo	NULL
,	NULL
HIV-infected	NULL
monocytic	NULL
cells	NULL
may	NULL
be	NULL
primed	NULL
in	NULL
some	NULL
manner	NULL
by	NULL
HIV	NULL
infection	NULL
such	NULL
that	NULL
subsequent	NULL
antigenic	NULL
stimulation	NULL
of	NULL
these	NULL
cells	NULL
leads	NULL
to	NULL
the	NULL
production	NULL
of	NULL
TNF	NULL
and	NULL
other	NULL
cytokines	NULL
.	NULL

TNF-a	NULL
may	NULL
not	NULL
significantly	NULL
augment	NULL
HIV	NULL
replication	NULL
in	NULL
the	NULL
myeloid	NULL
cell	NULL
reservoir	NULL
;	NULL
however	NULL
,	NULL
T	NULL
lymphoid	NULL
cells	NULL
,	NULL
a	NULL
primary	NULL
target	NULL
of	NULL
HIV	NULL
infection	NULL
are	NULL
highly	NULL
sensitive	NULL
to	NULL
the	NULL
T-cell-activating	NULL
effects	NULL
of	NULL
TNF-a	NULL
(	NULL
27	NULL
,	NULL
37	NULL
,	NULL
52	NULL
)	NULL
,	NULL
an	NULL
effect	NULL
mediated	NULL
in	NULL
part	NULL
by	NULL
activation	NULL
of	NULL
NF-KB	NULL
(	NULL
12	NULL
,	NULL
28	NULL
,	NULL
43	NULL
,	NULL
44	NULL
)	NULL
.	NULL

Continued	NULL
secretion	NULL
of	NULL
TNF-a	NULL
from	NULL
activated	NULL
,	NULL
HIV-infected	NULL
monocytic	NULL
cells	NULL
may	NULL
contribute	NULL
to	NULL
viral	NULL
pathogenesis	NULL
by	NULL
increasing	NULL
the	NULL
lytic	NULL
spread	NULL
of	NULL
HIV-1	NULL
through	NULL
a	NULL
T-cell	NULL
population	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
Health	NULL
and	NULL
Welfare	NULL
Canada	NULL
,	NULL
the	NULL
Medical	NULL
Research	NULL
Council	NULL
of	NULL
Canada	NULL
,	NULL
and	NULL
the	NULL
Cancer	NULL
Research	NULL
Society	NULL
.	NULL

J.L	NULL
.	NULL

is	NULL
the	NULL
recipient	NULL
of	NULL
a	NULL
studentship	NULL
from	NULL
FCAR	NULL
;	NULL
J.H	NULL
.	NULL

is	NULL
the	NULL
recipient	NULL
of	NULL
a	NULL
Senior	NULL
Chercheur-boursier	NULL
award	NULL
from	NULL
FRSQ	NULL
.	NULL

We	NULL
thank	NULL
Carl	NULL
Dieffenbach	NULL
for	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
GAPDH	NULL
primers	NULL
and	NULL
Sandy	NULL
Fraiberg	NULL
and	NULL
Rhona	NULL
Rosenzweig	NULL
for	NULL
typing	NULL
the	NULL
manuscript	NULL
.	NULL

LITERATURE	NULL
CITED	NULL
1	NULL
.	NULL

Asjo	NULL
,	NULL
B.	NULL
,	NULL
I.	NULL
Ivhed	NULL
,	NULL
M.	NULL
Gidlund	NULL
,	NULL
S.	NULL
Fuerstenberg	NULL
,	NULL
E.	NULL
M.	NULL
Fenyo	NULL
,	NULL
K.	NULL
Nilsson	NULL
,	NULL
and	NULL
H.	NULL
Wigzell	NULL
.	NULL

1987	NULL
.	NULL

Susceptibility	NULL
to	NULL
infection	NULL
by	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
correlates	NULL
with	NULL
T4	NULL
expression	NULL
in	NULL
a	NULL
parental	NULL
monocytoid	NULL
cell	NULL
line	NULL
and	NULL
its	NULL
subclones	NULL
.	NULL

Virology	NULL
157:359-365	NULL
.	NULL

2	NULL
.	NULL

Baeverle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
65-kD	NULL
subunit	NULL
of	NULL
EFFECT	NULL
OF	NULL
TNF-	NULL
«	NULL
ON	NULL
HIV	NULL
AND	NULL
IFN-B	NULL
GENE	NULL
EXPRESSION	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

4733	NULL
active	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
required	NULL
for	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
IxB	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:1689-1698.	NULL
.	NULL

Barre-Sinoussi	NULL
,	NULL
F.	NULL
,	NULL
J.	NULL
C.	NULL
Cherman	NULL
,	NULL
F.	NULL
Rey	NULL
,	NULL
M.	NULL
T.	NULL
Nugeyre	NULL
,	NULL
S.	NULL
Charmaret	NULL
,	NULL
J.	NULL
Gruest	NULL
,	NULL
C.	NULL
Dauguet	NULL
,	NULL
C.	NULL
Axlen-Blin	NULL
,	NULL
F.	NULL
Vezinet-Brun	NULL
,	NULL
C.	NULL
Rouzioux	NULL
,	NULL
W.	NULL
Rozenbaum	NULL
,	NULL
and	NULL
L.	NULL
Montagnier	NULL
.	NULL

1983	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
T-lymphotropic	NULL
retrovirus	NULL
from	NULL
a	NULL
patient	NULL
at	NULL
risk	NULL
for	NULL
acquired	NULL
immune	NULL
deficiency	NULL
syndrome	NULL
(	NULL
AIDS	NULL
)	NULL
.	NULL

Science	NULL
220:868-871.	NULL
.	NULL

Beutler	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
A.	NULL
Cerami	NULL
.	NULL

1988	NULL
.	NULL

Tumor	NULL
necrosis	NULL
,	NULL
cachexia	NULL
,	NULL
shock	NULL
,	NULL
and	NULL
inflammation	NULL
:	NULL
a	NULL
common	NULL
mediator	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

57:505-518.	NULL
.	NULL

Chomezynski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
N.	NULL
Sacchi	NULL
,	NULL
1987	NULL
.	NULL

Single	NULL
step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloro-form	NULL
extraction	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

162:156-159.	NULL
.	NULL

Clouse	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
D.	NULL
Powell	NULL
,	NULL
I.	NULL
Washington	NULL
,	NULL
G.	NULL
Poli	NULL
,	NULL
K.	NULL
Strebel	NULL
,	NULL
W.	NULL
Farrar	NULL
,	NULL
P.	NULL
Borstad	NULL
,	NULL
J.	NULL
Kovacs	NULL
,	NULL
A.	NULL
S.	NULL
Fauci	NULL
,	NULL
and	NULL
T.	NULL
M.	NULL
Folks	NULL
.	NULL

1989	NULL
.	NULL

Monokine	NULL
regulation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus-1	NULL
expression	NULL
in	NULL
a	NULL
chronically	NULL
infected	NULL
human	NULL
T-cell	NULL
clone	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

142:431-438.	NULL
.	NULL

Cullen	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1989	NULL
.	NULL

Regulatory	NULL
pathways	NULL
governing	NULL
HIV-1	NULL
replication	NULL
.	NULL

Cell	NULL
58:423-426.	NULL
.	NULL

Dalgleish	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
P.	NULL
C.	NULL
L.	NULL
Beverley	NULL
,	NULL
P.	NULL
R.	NULL
Clapham	NULL
,	NULL
D.	NULL
H.	NULL
Crawford	NULL
,	NULL
M.	NULL
F.	NULL
Greaves	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Weiss	NULL
.	NULL

1984	NULL
.	NULL

The	NULL
CD4	NULL
(	NULL
T4	NULL
)	NULL
antigen	NULL
is	NULL
an	NULL
essential	NULL
component	NULL
of	NULL
the	NULL
receptor	NULL
for	NULL
the	NULL
AIDS	NULL
retrovirus	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
312:763-767.	NULL
.	NULL

Duh	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
W.	NULL
J.	NULL
Maury	NULL
,	NULL
T.	NULL
M.	NULL
Folks	NULL
,	NULL
A.	NULL
S.	NULL
Fauci	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rabson	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
activates	NULL
human	NULL
immunodeficiency	NULL
virus-1	NULL
through	NULL
induction	NULL
of	NULL
nuclear	NULL
factor	NULL
binding	NULL
to	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
in	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:5974-5978	NULL
.	NULL

Fan	NULL
,	NULL
C.-M.	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1989	NULL
.	NULL

Two	NULL
different	NULL
virus-inducible	NULL
elements	NULL
are	NULL
required	NULL
for	NULL
human	NULL
B-interferon	NULL
gene	NULL
regulation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:101-110	NULL
.	NULL

Fauci	NULL
,	NULL
A.	NULL
S.	NULL
1988	NULL
.	NULL

The	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
:	NULL
infectivity	NULL
and	NULL
mechanisms	NULL
of	NULL
pathogenesis	NULL
.	NULL

Science	NULL
239:617-622	NULL
.	NULL

Folks	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
K.	NULL
A.	NULL
Clouse	NULL
,	NULL
J.	NULL
Justement	NULL
,	NULL
A.	NULL
Rabson	NULL
,	NULL
E.	NULL
Dut	NULL
,	NULL
J.	NULL
H.	NULL
Kerhl	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
induces	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
a	NULL
chronically	NULL
infected	NULL
T-cell	NULL
clone	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:2365-2368	NULL
.	NULL

Folks	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
S.	NULL
W.	NULL
Kessler	NULL
,	NULL
J.	NULL
M.	NULL
Orenstein	NULL
,	NULL
J.	NULL
S.	NULL
Justement	NULL
,	NULL
E.	NULL
S.	NULL
Jaffe	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1988	NULL
.	NULL

Infection	NULL
and	NULL
replication	NULL
of	NULL
HIV-1	NULL
in	NULL
purified	NULL
progenitor	NULL
cells	NULL
of	NULL
normal	NULL
human	NULL
bone	NULL
marrow	NULL
.	NULL

Science	NULL
242:919-922	NULL
.	NULL

Fujita	NULL
,	NULL
T.	NULL
,	NULL
M.	NULL
Miyamoto	NULL
,	NULL
Y.	NULL
Kimura	NULL
,	NULL
J	NULL
.	NULL

Hammer	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1989	NULL
.	NULL

Involvement	NULL
of	NULL
a	NULL
cis-element	NULL
that	NULL
binds	NULL
an	NULL
H2TF-1/NF-	NULL
«	NULL
B	NULL
like	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
in	NULL
the	NULL
virus-induced	NULL
interferon-B	NULL
gene	NULL
expression	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:3335-3346	NULL
.	NULL

Fujita	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
Sakakibara	NULL
,	NULL
Y.	NULL
Sudo	NULL
,	NULL
M.	NULL
Miyamoto	NULL
,	NULL
Y.	NULL
Kimura	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1988	NULL
.	NULL

Evidence	NULL
for	NULL
a	NULL
nuclear	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
,	NULL
IRF-1	NULL
,	NULL
mediating	NULL
induction	NULL
and	NULL
silencing	NULL
properties	NULL
to	NULL
human	NULL
IFN-B	NULL
gene	NULL
regulatory	NULL
elements	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

7:3397-3405	NULL
.	NULL

Fujita	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Shibuya	NULL
,	NULL
H.	NULL
Hotta	NULL
,	NULL
K.	NULL
Yamanishi	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1987	NULL
.	NULL

Interferon-B	NULL
gene	NULL
regulation	NULL
:	NULL
tandemly	NULL
repeated	NULL
sequences	NULL
of	NULL
a	NULL
synthetic	NULL
6	NULL
bp	NULL
oligomer	NULL
function	NULL
as	NULL
virus-inducible	NULL
enhancer	NULL
.	NULL

Cell	NULL
49:357-367	NULL
.	NULL

Gallo	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
S.	NULL
Z.	NULL
Salahuddin	NULL
,	NULL
M.	NULL
Popovic	NULL
,	NULL
G.	NULL
M.	NULL
Shearer	NULL
,	NULL
M.	NULL
Kaplan	NULL
,	NULL
B.	NULL
F.	NULL
Haynes	NULL
,	NULL
T.	NULL
J.	NULL
Palker	NULL
,	NULL
R.	NULL
Redfield	NULL
,	NULL
J.	NULL
Oleske	NULL
,	NULL
B.	NULL
Safai	NULL
,	NULL
F.	NULL
White	NULL
,	NULL
R.	NULL
Foster	NULL
,	NULL
and	NULL
P.	NULL
D.	NULL
Markham	NULL
.	NULL

1984	NULL
.	NULL

Frequent	NULL
detection	NULL
and	NULL
isolation	NULL
of	NULL
cytopathic	NULL
retroviruses	NULL
(	NULL
HTLV-II	NULL
)	NULL
from	NULL
patients	NULL
with	NULL
AIDS	NULL
and	NULL
at	NULL
risk	NULL
for	NULL
AIDS	NULL
.	NULL

Science	NULL
224:500-503	NULL
.	NULL

Gartner	NULL
,	NULL
S.	NULL
,	NULL
R.	NULL
F.	NULL
Markovitz	NULL
,	NULL
D.	NULL
M.	NULL
Markovitz	NULL
,	NULL
M.	NULL
H.	NULL
Kaplan	NULL
,	NULL
R.	NULL
C.	NULL
Gallo	NULL
,	NULL
and	NULL
M.	NULL
Popovic	NULL
.	NULL

1986	NULL
.	NULL

The	NULL
role	NULL
of	NULL
mononuclear	NULL
phagocytes	NULL
in	NULL
HTLV-III/LAV	NULL
infection	NULL
.	NULL

Science	NULL
233:215-219	NULL
.	NULL

Gendelman	NULL
,	NULL
H.	NULL
E.	NULL
,	NULL
O.	NULL
Narayan	NULL
,	NULL
S.	NULL
Molineaux	NULL
,	NULL
J.	NULL
E.	NULL
Clements	NULL
,	NULL
and	NULL
Z.	NULL
Gho	NULL
.	NULL

1985	NULL
.	NULL

Slow	NULL
,	NULL
persistent	NULL
replication	NULL
of	NULL
lentivirus	NULL
:	NULL
role	NULL
of	NULL
tissue	NULL
macrophages	NULL
and	NULL
macrophage	NULL
precursors	NULL
in	NULL
bone	NULL
marrow	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
82:7086-7090	NULL
.	NULL

Goldfeld	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1989	NULL
.	NULL

Coordinate	NULL
viral	NULL
induction	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
and	NULL
interferon	NULL
B	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
and	NULL
monocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:1490-1494	NULL
.	NULL

Goodbourn	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1988	NULL
.	NULL

Overlapping	NULL
positive	NULL
and	NULL
4734	NULL
22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

LACOSTE	NULL
ET	NULL
AL	NULL
.	NULL

negative	NULL
regulatory	NULL
domains	NULL
of	NULL
the	NULL
human	NULL
B-interferon	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:1447-1451	NULL
.	NULL

Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
L.	NULL
F.	NULL
Moffat	NULL
,	NULL
and	NULL
B.	NULL
H.	NULL
Howard	NULL
.	NULL

1982	NULL
.	NULL

Recombinant	NULL
genomes	NULL
which	NULL
express	NULL
chloramphenicol	NULL
acetyltransferase	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2:1044-1051	NULL
.	NULL

Grossschedl	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1985	NULL
.	NULL

Cell-type	NULL
specificity	NULL
of	NULL
immunoglobulin	NULL
gene	NULL
expression	NULL
is	NULL
regulated	NULL
by	NULL
at	NULL
least	NULL
three	NULL
DNA	NULL
sequence	NULL
elements	NULL
.	NULL

Cell	NULL
41:885-897	NULL
.	NULL

Hiscott	NULL
,	NULL
J.	NULL
,	NULL
D.	NULL
Alper	NULL
,	NULL
L.	NULL
Cohen	NULL
,	NULL
J.-F.	NULL
Leblanc	NULL
,	NULL
L.	NULL
Sportza	NULL
,	NULL
A.	NULL
Wong	NULL
,	NULL
and	NULL
S.	NULL
Xanthoudakis	NULL
.	NULL

1989	NULL
.	NULL

Induction	NULL
of	NULL
human	NULL
interferon	NULL
gene	NULL
expression	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
nuclear	NULL
factor	NULL
that	NULL
interacts	NULL
with	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
enhancer	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:2557-2566	NULL
.	NULL

Hiscott	NULL
,	NULL
J.	NULL
,	NULL
A.	NULL
Wong	NULL
,	NULL
D.	NULL
Alper	NULL
,	NULL
and	NULL
S.	NULL
Xanthoudakis	NULL
.	NULL

1988	NULL
.	NULL

Trans-activation	NULL
of	NULL
the	NULL
type	NULL
1	NULL
interferon	NULL
promoters	NULL
by	NULL
simian	NULL
virus	NULL
40	NULL
T	NULL
antigen	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:3397-3405	NULL
.	NULL

Ho	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
T.	NULL
R.	NULL
Rota	NULL
,	NULL
and	NULL
M.	NULL
S.	NULL
Hirsch	NULL
.	NULL

1986	NULL
.	NULL

Infection	NULL
of	NULL
monocytes/macrophages	NULL
by	NULL
human	NULL
T	NULL
lymphotropic	NULL
virus	NULL
type	NULL
III	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

77:1712-1715	NULL
.	NULL

Hurme	NULL
,	NULL
M.	NULL
1988	NULL
.	NULL

Both	NULL
interleukin-1	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
enhance	NULL
thymocyte	NULL
proliferation	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

18:1303-1306	NULL
.	NULL

Israel	NULL
,	NULL
N.	NULL
,	NULL
U.	NULL
Hazan	NULL
,	NULL
J.	NULL
Alcami	NULL
,	NULL
A.	NULL
Munier	NULL
,	NULL
F.	NULL
Arenzanaseisde-dos	NULL
,	NULL
T.	NULL
Bacherlerie	NULL
,	NULL
A.	NULL
Israel	NULL
,	NULL
and	NULL
J.-L.	NULL
Virelizier	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
stimulates	NULL
transcription	NULL
HIV-1	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
,	NULL
independently	NULL
and	NULL
synergistically	NULL
with	NULL
antigens	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

143:3956-3960	NULL
.	NULL

Jacobsen	NULL
,	NULL
H.	NULL
,	NULL
J.	NULL
Mestan	NULL
,	NULL
S.	NULL
Mittnacht	NULL
,	NULL
and	NULL
C.	NULL
W.	NULL
Dieffenbach	NULL
.	NULL

1989	NULL
.	NULL

Beta	NULL
interferon	NULL
subtype	NULL
1	NULL
induction	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:3037-3042	NULL
.	NULL

Klatzmann	NULL
,	NULL
D.	NULL
,	NULL
E.	NULL
Champagne	NULL
,	NULL
S.	NULL
Chamaret	NULL
,	NULL
J.	NULL
Gruest	NULL
,	NULL
D.	NULL
Guetard	NULL
,	NULL
T.	NULL
Hercend	NULL
,	NULL
J.	NULL
C.	NULL
Gluckman	NULL
,	NULL
and	NULL
L.	NULL
Montagnier	NULL
.	NULL

1984	NULL
.	NULL

T-lymphocyte	NULL
T4	NULL
molecule	NULL
behaves	NULL
as	NULL
the	NULL
receptor	NULL
for	NULL
human	NULL
retrovirus	NULL
LAV	NULL
.	NULL

Nature	NULL
312:767-768	NULL
.	NULL

Leblanc	NULL
,	NULL
J.-F.	NULL
,	NULL
L.	NULL
Cohen	NULL
,	NULL
M.	NULL
Rodrigues	NULL
,	NULL
and	NULL
J.	NULL
Hiscott	NULL
.	NULL

1990	NULL
.	NULL

Synergism	NULL
between	NULL
distinct	NULL
enhanson	NULL
domains	NULL
in	NULL
viral	NULL
induction	NULL
of	NULL
the	NULL
human	NULL
beta	NULL
interferon	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:3987-3993	NULL
.	NULL

Leonard	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
C.	NULL
Parrot	NULL
,	NULL
A.	NULL
J.	NULL
Buckler-White	NULL
,	NULL
W.	NULL
Turner	NULL
,	NULL
E.	NULL
K.	NULL
Ross	NULL
,	NULL
M.	NULL
T.	NULL
Martin	NULL
,	NULL
and	NULL
A.	NULL
J.	NULL
Rabson	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
are	NULL
not	NULL
required	NULL
for	NULL
virus	NULL
infectivity	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:4919-4924	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
:	NULL
a	NULL
pleiotropic	NULL
mediator	NULL
of	NULL
inducible	NULL
and	NULL
tissue-specific	NULL
gene	NULL
control	NULL
.	NULL

Cell	NULL
58:227-229	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
C.	NULL
M.	NULL
Fan	NULL
,	NULL
T.	NULL
Maniatis	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
involvement	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
B-interferon	NULL
gene	NULL
regulation	NULL
reveals	NULL
its	NULL
role	NULL
as	NULL
widely	NULL
inducible	NULL
mediator	NULL
of	NULL
signal	NULL
transduc-tion	NULL
.	NULL

Cell	NULL
57:287-294	NULL
.	NULL

Levy	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
J.	NULL
Shimabukuro	NULL
,	NULL
T.	NULL
McHugh	NULL
,	NULL
C.	NULL
Casavant	NULL
,	NULL
D.	NULL
Stites	NULL
,	NULL
and	NULL
L.	NULL
Oshiro	NULL
.	NULL

1985	NULL
.	NULL

AIDS-associated	NULL
retroviruses	NULL
(	NULL
ARV	NULL
)	NULL
can	NULL
productively	NULL
infect	NULL
other	NULL
cells	NULL
besides	NULL
human	NULL
T	NULL
helper	NULL
cells	NULL
.	NULL

Virology	NULL
147:441-448	NULL
.	NULL

Macchi	NULL
,	NULL
M.	NULL
,	NULL
J.-M.	NULL
Bornert	NULL
,	NULL
I.	NULL
Davidson	NULL
,	NULL
M.	NULL
Kanno	NULL
,	NULL
R.	NULL
Rosales	NULL
,	NULL
M.	NULL
Vigneron	NULL
,	NULL
J.-H.	NULL
Xiao	NULL
,	NULL
C.	NULL
Fromental	NULL
,	NULL
and	NULL
P.	NULL
Chambon	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
SV40	NULL
TC-II	NULL
kB	NULL
enhanson	NULL
binds	NULL
ubiquitous	NULL
and	NULL
cell	NULL
type	NULL
specifically	NULL
inducible	NULL
nuclear	NULL
proteins	NULL
from	NULL
lymphoid	NULL
and	NULL
non-lymphoid	NULL
cell	NULL
lines	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:4215-4227	NULL
.	NULL

Matsuyama	NULL
,	NULL
T.	NULL
,	NULL
Y.	NULL
Hamamoto	NULL
,	NULL
Y.	NULL
,	NULL
G.-I	NULL
.	NULL

Soma	NULL
,	NULL
D.	NULL
I.	NULL
Mizuno	NULL
,	NULL
N.	NULL
Yamamoto	NULL
,	NULL
and	NULL
N.	NULL
Kobayashi	NULL
.	NULL

1989	NULL
.	NULL

Cytocidal	NULL
effects	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
on	NULL
cells	NULL
chronically	NULL
infected	NULL
with	NULL
human	NULL
immu-	NULL
38	NULL
.	NULL

39	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

J.	NULL
ViroL	NULL
.	NULL

nodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
:	NULL
enhancement	NULL
of	NULL
HIV	NULL
replication	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:2504-2509	NULL
.	NULL

Merrill	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Y.	NULL
Koyanagi	NULL
,	NULL
and	NULL
I.	NULL
S.	NULL
Y.	NULL
Chen	NULL
.	NULL

1989	NULL
.	NULL

Interleukin-1	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
can	NULL
be	NULL
induced	NULL
from	NULL
mononuclear	NULL
phagocytes	NULL
by	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
binding	NULL
to	NULL
CD4	NULL
receptor	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:4404-4408	NULL
.	NULL

Mitchell	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1989	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
in	NULL
mammalian	NULL
cells	NULL
by	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

Science	NULL
245:371-378.	NULL
.	NULL

Mullis	NULL
,	NULL
K.	NULL
B.	NULL
,	NULL
and	NULL
F.	NULL
A.	NULL
Faloona	NULL
.	NULL

1987	NULL
.	NULL

Specific	NULL
synthesis	NULL
of	NULL
DNA	NULL
in	NULL
vitro	NULL
via	NULL
a	NULL
polymerase-catalyzed	NULL
chain	NULL
reaction	NULL
.	NULL

Methods	NULL
Enzymol	NULL
.	NULL

155:335-350	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

An	NULL
inducible	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
326:711-713	NULL
.	NULL

Nedwin	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
S.	NULL
L.	NULL
Naylor	NULL
,	NULL
A.	NULL
Y.	NULL
Sakaguchi	NULL
,	NULL
D.	NULL
Smith	NULL
,	NULL
J.	NULL
J.	NULL
Nedwin	NULL
,	NULL
D.	NULL
Pennica	NULL
,	NULL
D.	NULL
V.	NULL
Goeddel	NULL
,	NULL
and	NULL
P.	NULL
W.	NULL
Gray	NULL
,	NULL
1985	NULL
.	NULL

Human	NULL
lymphotoxin	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
genes	NULL
:	NULL
structure	NULL
,	NULL
homology	NULL
and	NULL
chromosomal	NULL
localization	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

13:6361-6371	NULL
.	NULL

Osborn	NULL
,	NULL
L.	NULL
,	NULL
S.	NULL
Kunkel	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
and	NULL
interleukin-1	NULL
stimulate	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
enhancer	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
kB	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:2336-2340.	NULL
.	NULL

Poli	NULL
,	NULL
G.	NULL
,	NULL
A.	NULL
Kinter	NULL
,	NULL
J.	NULL
S.	NULL
Justement	NULL
,	NULL
J.	NULL
H.	NULL
Kerhl	NULL
,	NULL
P.	NULL
Bressler	NULL
,	NULL
S.	NULL
Stanley	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1990	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
functions	NULL
in	NULL
an	NULL
autocrine	NULL
manner	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
expression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:782-785	NULL
.	NULL

Popovic	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
G.	NULL
Sarngadharan	NULL
,	NULL
E.	NULL
Read	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Gallo	NULL
.	NULL

1984	NULL
.	NULL

Detection	NULL
,	NULL
isolation	NULL
,	NULL
and	NULL
continuous	NULL
production	NULL
of	NULL
cytopathic	NULL
human	NULL
T	NULL
lymphotropic	NULL
retrovirus	NULL
(	NULL
HTLV-III	NULL
)	NULL
from	NULL
patients	NULL
with	NULL
AIDS	NULL
and	NULL
pre-AIDS	NULL
.	NULL

Science	NULL
224:497-500.	NULL
.	NULL

Roy	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Wainberg	NULL
.	NULL

1988	NULL
.	NULL

Role	NULL
of	NULL
the	NULL
mononuclear	NULL
phagocyte	NULL
system	NULL
in	NULL
the	NULL
development	NULL
of	NULL
acquired	NULL
immunodeficiency	NULL
syndrome	NULL
(	NULL
AIDS	NULL
)	NULL
.	NULL

J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

43:91-98	NULL
.	NULL

Taniguchi	NULL
,	NULL
T.	NULL
1988	NULL
.	NULL

Regulation	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

6:439-464	NULL
.	NULL

Visvanathan	NULL
,	NULL
K.	NULL
V.	NULL
,	NULL
and	NULL
S.	NULL
Goodbourn	NULL
.	NULL

1989	NULL
.	NULL

Double-stranded	NULL
RNA	NULL
activates	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
an	NULL
inducible	NULL
element	NULL
in	NULL
the	NULL
human	NULL
B-interferon	NULL
promoter	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:1129-1138	NULL
.	NULL

Voth	NULL
,	NULL
R.	NULL
,	NULL
S.	NULL
Rossol	NULL
,	NULL
K.	NULL
Klein	NULL
,	NULL
G.	NULL
Hess	NULL
,	NULL
K.	NULL
Schiitt	NULL
,	NULL
H.	NULL
Schroder	NULL
,	NULL
K.	NULL
Meyer	NULL
Zum	NULL
Biischenfelde	NULL
,	NULL
and	NULL
W.	NULL
Miller	NULL
.	NULL

1990	NULL
.	NULL

Differential	NULL
gene	NULL
expression	NULL
of	NULL
IFN-a	NULL
«	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
in	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
from	NULL
patients	NULL
with	NULL
AIDS	NULL
related	NULL
complex	NULL
and	NULL
AIDS	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

144:970-975	NULL
.	NULL

Wright	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
A.	NULL
Jewett	NULL
,	NULL
R.	NULL
Mutsuyasu	NULL
,	NULL
and	NULL
B.	NULL
Bonavida	NULL
.	NULL

1988	NULL
.	NULL

Spontaneous	NULL
cytotoxicity	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
production	NULL
by	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
from	NULL
AIDS	NULL
patients	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

141:99-104	NULL
.	NULL

Xanthoudakis	NULL
,	NULL
S.	NULL
,	NULL
D.	NULL
Alper	NULL
,	NULL
and	NULL
J.	NULL
Hiscott	NULL
.	NULL

1987	NULL
.	NULL

Transient	NULL
expression	NULL
of	NULL
the	NULL
beta	NULL
interferon	NULL
promoter	NULL
in	NULL
human	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7:3830-3835	NULL
.	NULL

Yokota	NULL
,	NULL
S.	NULL
,	NULL
T.	NULL
D.	NULL
Geppert	NULL
,	NULL
and	NULL
P.	NULL
E.	NULL
Lipsky	NULL
.	NULL

1988	NULL
.	NULL

Enhancement	NULL
of	NULL
antigen-	NULL
and	NULL
mitogen-induced	NULL
human	NULL
T	NULL
lumphocytes	NULL
proliferation	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

140:531-536	NULL
.	NULL

Zabel	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1990	NULL
.	NULL

Purified	NULL
human	NULL
IxB	NULL
can	NULL
rapidly	NULL
dissociate	NULL
the	NULL
complex	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
with	NULL
its	NULL
cognate	NULL
DNA	NULL
.	NULL

Cell	NULL
61:255-265	NULL
.	NULL

Zinn	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1986	NULL
.	NULL

Detection	NULL
of	NULL
factors	NULL
that	NULL
interact	NULL
with	NULL
the	NULL
human	NULL
B-interferon	NULL
regulatory	NULL
region	NULL
in	NULL
vivo	NULL
by	NULL
DNase	NULL
I	NULL
footprinting	NULL
.	NULL

Cell	NULL
45:611-618	NULL
.	NULL

